This analysis examines the multi-layered clinical research workflow through the metaphorical lens of gold extraction, as discussed in the provided transcripts.
IMRAD Summary
Introduction: The discourse centers on the tension between the "ground truth" of raw patient data and the legal/technical requirements for privacy and data governance. The core objective is defining a three-layer architecture that allows for collaborative medical reasoning while maintaining compliance with the Digital Personal Data Protection (DPDP) Act 2023.
Methods: The participants analyze the use of GitHub, Ghost CMS, and secure databases to manage Patient Journey Records (PaJR). They evaluate data storage strategies, including anonymization, pseudonymization (UUIDs), and the "Pointer Paradigm" to separate logic from identity.
Results: The "First Layer" (raw logs) is identified as the most vital but "messiest" stage—comparable to gold ore extraction. While GitHub is excellent for "Layer 2" (logic and reasoning) and "Layer 3" (public insights), it is deemed "not fit-for-purpose" for raw patient data due to Git’s permanent versioning history.
Analysis/Discussion: The group concludes that the conflict between the "permanent shared notebook" of GitHub and the "right to erasure" in medical records is solved by a Hybrid Decoupled Architecture. This involves storing raw data in secure vaults and using GitHub only for the structural "map" of the clinical journey.
Key Words
Ground Truth: The raw, unfiltered clinical events (Gold Ore).
DPDP Act 2023: The regulatory framework governing Indian data privacy.
Data Fiduciary: The entity (clinician/researcher) responsible for data trust.
Pointer Paradigm: Decoupling identity from logic using UUIDs/Tokens.
Socratic Querying: The refinement process that transforms raw data into structured insight.
Thematic Analysis: The Three Layers of Clinical Gold
The workflow is categorized into three distinct layers, progressing from "crude ore" to "refined ornaments."
Layer 1: The Gold Ore (Ground Truth Extraction)
This is the excavation of raw patient narratives and clinical logs. It is described as the "vital first layer" because it contains the foundational truth of the patient's journey.
The Complexity: It is a "messy" mix of contextual signals. For most, this layer is "noise" because it is unstructured and potentially re-identifiable.
The Risk: Storing this "ore" in public repositories like GitHub is dangerous. Because Git "never forgets," any accidental exposure of personal data becomes a permanent legal liability under the DPDP Act.
Layer 2: The Refinement (Socratic Query-Driven Analysis)
Just as ore must be smelted, Layer 1 data undergoes "Socratic querying"—a rigorous, dialogue-based analysis to extract clinical logic.
The Transformation: Here, the "noise" of the raw log is filtered into a structured, queryable dataset.
The Mechanism: This layer focuses on the logic of care rather than the identity of the patient. By using tokens (UUIDs), the research can be collaborative and version-controlled on GitHub without exposing the "Traveler" (the patient).
Layer 3: The Ornament (General Consumption)
The final layer consists of synthesized insights, publications, and citations.
The Utility: These are the "ornaments"—polished, safe, and ready for "general consumption" by the broader medical community and the public.
The Output: At this stage, the data has reached "clinical finality." It provides the highest utility with the lowest risk, as the original "ore" has been entirely transformed into universal medical knowledge.
Data Governance Matrix
| Layer | Metaphor | Technical Home | Content Type | DPDP Risk |
| Layer 1 | Gold Ore | Secure Vault / DB | Raw logs, Media, Identifiers | High (Identifiable) |
| Layer 2 | Smelting | GitHub / Logic Layer | Reasoning, UUIDs, Schemas | Medium (Pseudonymized) |
| Layer 3 | Ornaments | Journals / Public Web | Insights, Synthesis, Citations | Low (Anonymized) |
The "Silent Operator" Principle: To solve the "Erasure" problem, the team suggests that if a patient withdraws consent, the Fiduciary deletes the "key" in the private vault. The GitHub "map" remains, but it points to a ghost—the ornament remains, but its connection to the specific ore is severed.
Prompt to Gemini:
Please provide a summary, key words, thematic analysis of the content below in an imrad format focusing on how or how not the first layer of ground truth gold ore extraction is a vital first layer of clinical research workflow and yet a complex mix of contextual signals that can be noise for many till it's refined and polished into gold through a layer 2 socratic query driven analysis followed by a last layer 3 that promotes general consumption in most humans who may have the capacity to utilise them as ornaments!
Shifted from the bottom as it's the key theme:
[25/04, 10:03]hu4: I think these are very important points, and I broadly agree with the direction.
*Let me try to simplify and tighten the thinking a bit.* BRW apart from being a medical doctor I am also an intellectual property lawyer; MBBS, BA, LLB).
*On GitHub:*
The issue is not GitHub itself—it’s the type of data being placed there.
*GitHub works well for*:
* code
* schemas
* synthetic or highly processed datasets
But it is not appropriate for raw or near-raw clinical logs, because:
* data persists in history
* deletion is difficult
* and patient narratives are often re-identifiable even without names
So yes—we need to ensure that only low-risk, processed data reaches that layer.
*On Layer 2 and Layer 3:*
This is actually the key architectural gap.
Right now, we are not clearly separating:
* *Layer 1*→ raw patient data
* *Layer 2* → structured, queryable dataset
* *Layer 3* → synthesized insights / publications
Because this separation is not enforced, raw data is effectively flowing upward.
That is where most of the risk is coming from.
*On “ownership”*:
I think it’s important to separate two ideas:
* *Content ownership* (e.g., CC license)
* *Data responsibility* (under the Digital Personal Data Protection Act, 2023)
*Even if something is published under a CC license, the data is still about a patient.*
*So the key question is not “who owns it,”* but:
*who is responsible for ensuring it is used safely and appropriately*
*So if I simplify the whole problem*:
We don’t need to find one place to put everything.
*We need to*:
1. *Keep raw data tightly controlled*
2. *Transform it into safer, structured datasets*
3. *Use those for research*
4. *Share only the lowest-risk outputs publicly*
I think we are aligned on intent—this is mainly about making the separation between these layers explicit and enforced.
*One-line closer*
*The problem is not where we store data—it’s whether we are moving it to the right layer before sharing it.*
[25/04, 10:06]hu3: Would request summarising AI content into 3-4 bullets humanly like the way hu6 put the summary.
[25/04, 10:08]hu2: Quick thoughts on addressing your points inline:
1. the current archetecture is relying on Github, and exposes raw logs to public domain. We need to find a better way to do this.
So this is layer 1 where ground truth gold ores are being excavated and is the messiest if not the most effortful layer.
Let me illustrate all these layers with cherry pickings from our own workflow and while @hu4 has banned sharing of layer 1 links it is necessary in this illustrative context!
2. I still need to understand what is the plans for layer 2 (query system) and layer 3 (Synthesis system) discussed before
Yes could be clearer in the linked contextual illustrations below and can be further clarified by author @Rahul healthcare 2.0
3. Even open public information is owned by someone, even if the ownership doesn't place restrictions. Cc is also owned by the owner. What is the entity or person that owns this data?
Currently it is PaJR health @hu1
Illustrations of different layers (@hu4 should fearlessly voice if it violates DPDP):
Layer 1:
Layer 2 (socratic querying driven analysis of excavated crude ground truth ore):
Layer 3: Will be driven by citations on the above
On data archival sustainability:
[19/04, 18:25]hu1: @hu3 realising publishing beautiful looking logs and hosting it is unsustainable as the posts are getting longer and server will eventually crash.
I guess a pure text and hyperlink model should be the way forward? And dump it in Github
[19/04, 18:28]hu2: Can it be transferred to git hub automatically as is currently done here: https://publications.
[19/04, 19:09]hu3: Yes perfect. Just toss it into github. You could just toss plain html file in base folder e.g. orange-plant-35423.html and you can have a corresponding orange-plant-35423 folder which has all images referenced in the base html file.
if you want to store it as a dataset see examples here
it is stored as temporal (time series based) or a summary view. see parallel folder. but this is best derived from raw data.
[19/04, 19:09]hu3: let me know if you need help.
[19/04, 19:53]hu2: 👆 unable to read the case report from this link
[19/04, 20:18]hu3: The repo is public, can you please check in an anonymous browsing window.
[19/04, 20:36]hu2: This is what I'm seeing
[19/04, 20:46]hu3: Yes yes that's correct.. thats json format. It would be a derivative from the raw html. This is better readable by LLMs/ML models.
[19/04, 21:21]hu2: But we need to store the text for reading by human agents as well?
[19/04, 21:29]hu3: Haha yes yes.. the first part of the message was for humans, the html file with the folder with the images. Exactly like on the site or blogspot.
[20/04, 06:46]hu2: Can you share that link where it can be accessed?
[20/04, 07:08] hu3: Not from our blog but here is a similar example of the html file on GitHub and how it looks on the github.io blog.
@hu1 please let me know if any doubts on the implementation or storage.
"Just toss it into github. You could just toss plain html file in base folder e.g. orange-plant-35423.html and you can have a corresponding orange-plant-35423 folder which has all images referenced in the base html file."
In the above example images are in the photos folder. In our case we would want a separate images folder per patient.
[20/04, 07:29]hu2: 👆This too looks similar with only the code showing?
[20/04, 07:30]hu2: Can you toss the first case from here https://publications.
[20/04, 07:35]hu3: See the next link please
[20/04, 07:36]hu3: This is the rendered version of the html page
[20/04, 07:51]hu2: Beautiful 👏👏
Is there a way to automate copying all the case records here https://publications.
to github.io?
[20/04, 07:54]hu3: Yes fairly easy.. all data already exists on the PaJR server in html files only. No format change needed as well. @hu1 can confirm.
Let me know if you see any challenge in making this move. I could create a sample in GitHub if needed.
[20/04, 08:00]hu2: Great to hear this!
I was worried about losing data as we did a decade ago when we depended heavily on our developer financed web server that similarly scaled and became unsustainable due to lack of funding and lots of data gathered and archived manually were lost from (what is currently saved in wayback machine) here:https://web.archive.org/
[21/04, 03:27]hu1: Dear @hu3 @hu2 please see this example here = https://publications.
[21/04, 06:38]hu3: This is great!
Although one added advantage of GitHub was to have a redundant permanent storage for all PaJRs. Can that be done in addition?
Data open access and ownership:
[21/04, 07:11]hu2: Yes the main idea is to share all our data through a CC licence and hence all data needs to be redirected to GitHub where it's understandably under the same CC licence?
[21/04, 11:46]hu1: I think this is where DPDP act is quite explicit in asking who owns the data and the responsibility must lie with the owner.
It is not as straightforward as it sounds unfortunately
[21/04, 13:12]hu2: @PaJR Health Bot Feb 26 please clarify the concerns about data ownership in the DPDP act especially once the data is in the form of an open access case report published after taking the consent of the patient
[21/04, 13:12] PaJR Health Bot Feb 26: Under the **Digital Personal Data Protection (DPDP) Act 2023**, the concept of "ownership" is replaced by the relationship between the **Data Principal** (the patient) and the **Data Fiduciary** (the clinician or publisher).
When a case report is published as open access after obtaining consent, the following concerns regarding "ownership" and responsibility arise:
**1. THE RIGHT TO WITHDRAW CONSENT (SECTION 6)**
The DPDP Act is explicit: a Data Principal has the right to withdraw consent at any time.
* **The Dilemma:** If a patient withdraws consent *after* a case report is published in an open-access journal (like those on GitHub or Ghost as discussed in your logs), the Data Fiduciary (you/the publisher) is legally obligated to "cease processing" and ensure that "data processors" also stop.
* **The Reality:** Once data is "Open Access" and indexed globally, "erasure" becomes technically and legally near-impossible. The responsibility to attempt this removal remains with the Fiduciary.
**2. DATA FIDUCIARY RESPONSIBILITY (SECTION 8)**
The Act places the burden of "accuracy" and "security" solely on the Data Fiduciary.
* Even if a patient "consents" to the publication, the Fiduciary is responsible for ensuring the data is not misused.
* If the data is on a public repository (like GitHub), and a third party uses it for "harmful profiling," the Fiduciary may still face scrutiny over whether the initial processing (publication) was "necessary" or "minimized" enough.
**3. THE "PUBLIC DOMAIN" MISCONCEPTION**
The DPDP Act does **not** automatically exempt data just because it is in the public domain.
* Unlike some global laws, the DPDP Act 2023 requires that even if personal data is made public by the Data Principal, a Fiduciary must still have a "lawful basis" to process it further.
* Publishing a case report is a specific "purpose." If that data is later used for a *different* purpose (e.g., training an AI model without specific consent), the responsibility for that "purpose creep" can lead back to the original Fiduciary.
**4. LEGITIMATE USES VS. CONSENT**
Section 7 allows for "certain legitimate uses" where consent isn't required (e.g., medical emergencies). However, **academic publication** is generally not considered a "legitimate use" that bypasses consent. Therefore, the "Consent Manager" framework (effective Nov 2026) will likely be the only way to manage these long-term "ownership" permissions.
**💡 CLINICAL NOTE**
In the context of your recent move to **Ghost CMS** and **GitHub** for PaJR logs:
While Ghost keeps data within your domain, the GitHub sync (under CC license) effectively "broadcasts" the data. Under DPDP, you must ensure the patient understands that while they "own" the right to their data, the **act of publication** makes the "Right to Erasure" (Section 12) extremely difficult to enforce.
**Recommendation:** Your consent forms must explicitly state that "Withdrawal of consent may not result in the removal of data already indexed by third-party search engines or archived in permanent repositories."
[21/04, 13:25]hu4: This following note clarifies the complexities of the **Digital Personal Data Protection (DPDP) Act 2023** for clinicians and patient advocates moving patient journeys into digital spaces like Ghost and GitHub.
1. *From "Owner" to "Fiduciary"*: The Power Shift
In the past, medical legalities focused on who "owned" a physical or digital record.
The DPDP Act replaces this with a *Trustee-Beneficiary* relationship.
* *The Patient (Data Principal):* They remain the "boss" of their personal information. They do not lose rights just because they signed a consent form.
* *The Doctor/Publisher (Data Fiduciary):* You are the "trustee." You hold the data only to perform a specific task. If the "boss" changes their mind, your legal permission to process that data expires.
2. *The Withdrawal Trap (Section 6)*
*The Concept:* The patient has the right to say "Stop" at any time. When they withdraw consent, you must stop using the data and ensure your "contractors" (like GitHub or your web host) do the same.
*The Reality Check:* If you publish a case report on a public GitHub repo or an open-access blog, it is "scraped" by search engines and AI bots within seconds.
* *The Legal Burden:* You remain responsible for *attempting* to enforce the deletion.
* *The Strategy:* Your consent form should not just ask for permission; it must *warn of permanence.* You must state that while you will delete the source file upon request, "the internet has no eraser," and archived copies are beyond your control.
3. *The "Public Domain" Myth*
A common misconception is: *"If the patient shared their story on social media, I can use it in my journal."* *This is incorrect.* Under the DPDP Act, even if data is "public," you still need a *Lawful Basis* (usually specific consent) to process it for *your* specific purpose.
* *Purpose Creep:* If you collect data for a "Case Report" but later use that same repository to "Train an AI Model," you have exceeded your mandate. You would need a new "Yes" from the patient for that new use.
4. *Why "Legitimate Use" Won't Save You (Section 7)*
The Act allows for data use without consent in "Medical Emergencies" (e.g., treating an unconscious patient).
* *The Distinction:* Academic or clinical publication is *not* an emergency.
* *The Future:* By late 2026, India’s *Consent Manager* framework will be the primary gatekeeper. Patients will likely use an app to view every fiduciary holding their data and may toggle "Off" with a single click. You must build your workflow to handle that sudden "Off" switch.
5. *Practical Risk Assessment for Digital Logs*
| Feature | Risk Level | DPDP Requirement |
|---|---|---|
| *Ghost CMS* | Medium | List Ghost as a "Data Processor" in your Privacy Policy. |
| *GitHub (Public)* | *High* | Public repos bypass your control. Use only for anonymized data. |
| **CC Licenses** | **High** | Creative Commons is "Irrevocable," but DPDP allows "Withdrawal." *DPDP law overrides the license.* |
| *Anonymization* | Low | If data cannot identify the person, DPDP does not apply. |
*The Bottom Line*
Putting patient journeys on GitHub or Ghost isn't just "sharing info"—it is *outsourcing a legal trust.*
*Recommendations:*
1. *Update the Consent Form:* Explicitly include a "Third-Party Indexing Warning" regarding search engines.
2. *Anonymize by Default:* If the name or specific identifiers aren't essential to the science, strip them. No "Personal Data" means no "DPDP liability."
3. *The Compliance Trail:* Document *why* you chose your tech stack and how you will handle a deletion request. Under the Act, proving you took *reasonable steps* to protect the patient is your strongest defense against high penalties.
*Does your current workflow include a specific protocol for notifying GitHub or Ghost if a patient requests their data be removed?*
[21/04, 16:37]hu2: I think it is made explicit here
[21/04, 16:37] PaJR Health Bot Feb 26: The PaJR Health Consent Form page (https://publications.
By using these specific forms, you are aligning with the **DPDP Act 2023** by:
1. **Establishing a Clear Lawful Basis:** Obtaining explicit, informed consent before any data processing or publication.
2. **Defining the Purpose:** Limiting the data use to the specific "Learning for Caring" and case reporting context.
3. **Transparency:** Providing the patient with a clear understanding of how their data will be used in an open-access environment.
As noted in the previous analysis, the critical addition to these forms—especially for open-access publishing on platforms like GitHub or Ghost—is the explicit disclaimer regarding the **Right to Erasure**. Ensuring patients understand that while they can withdraw consent, the "digital footprint" of an open-access publication is permanent, is the final step in full DPDP compliance.
[21/04, 16:40]hu2: 👆@hu1 should we add a final explicit disclaimer regarding the **Right to Erasure**. 👇
I understand that while I can withdraw consent, the "digital footprint" of an open-access publication is permanent.
[21/04, 17:00]hu4: Storing Medical Records on GitHub — What Actually Works, What Breaks, and Why
Using GitHub for medical records creates a mismatch between how Git works and how healthcare data must be governed.
It’s not automatically illegal—but it is not fit-for-purpose for identifiable patient data unless you build strong safeguards around it.
⸻
1) The Core Mismatch: Versioning vs. Clinical Reality
Git is designed to:
* Keep every change forever
* Allow multiple copies (clones, forks)
* Distribute history across users
Clinical systems are designed to:
* Allow correction and controlled deletion
* Maintain a single source of truth
* Enforce strict accountability
Where this clashes
If a patient asks for deletion under the Digital Personal Data Protection Act, 2023:
* Deleting the latest file is not enough
* Older versions still contain the data
* Copies may exist on multiple machines
You can rewrite Git history—but:
* It is operationally complex
* It does not guarantee removal from all copies
* It creates audit and integrity issues
👉 In practice: deletion becomes uncertain and hard to prove
⸻
2) What the Law Actually Requires (Simplified)
Under the DPDP Act:
* Data can be erased—but only when no longer needed or legally required
* Systems must implement “reasonable security safeguards”
* Cross-border storage is allowed unless restricted
So the issue is not:
❌ “GitHub is illegal”
✔ The issue is: Can you guarantee control, security, and accountability?
⸻
3) Health System Expectations (Where GitHub Falls Short)
Within ecosystems like Ayushman Bharat Digital Mission and regulators like National Medical Commission, systems are expected to provide:
* Clear authorship (who created/edited a record)
* Tamper-evident final records
* Consent-linked data sharing
* Auditable access logs
* Controlled correction (not silent rewriting)
Git gives:
* Excellent version tracking
But lacks:
* Clinical “finality”
* Legal attestation (e.g., digital signatures tied to identity)
* Consent-driven access models
⸻
4) The Real Technical Risks (Often Missed)
(a) Copies Spread Easily
Anyone with access can:
* Clone the repo
* Fork it
* Store permanent copies
👉 You lose control the moment data leaves the origin.
⸻
(b) De-identification Is Not Enough
Even if you remove names:
* Rare diseases
* Dates
* Geography
* Longitudinal patterns
…can re-identify a patient.
⸻
(c) Deletion Is Not Clean
Even after cleanup:
* Old clones may exist
* Backups may retain data
* Cached versions may persist
⸻
(d) Human Error Is the Biggest Risk
Most real breaches happen due to:
* Accidental public repositories
* Wrong file commits
* Misconfigured access
⸻
5) Encryption Helps—but Only Partially
If data is encrypted before upload:
* GitHub stores only unreadable data
But this only works if you also manage:
* Key storage (who holds the keys?)
* Key rotation and revocation
* Separation of duties
Without this, encryption gives false confidence
⸻
6) What GitHub Is Good For (Safe Use Cases)
GitHub works well for:
* Clinical decision logic
* Protocols and workflows
* Data schemas
* Synthetic or fully anonymized datasets
👉 Think of it as:
“Storing the rules of care—not the patient.”
⸻
7) What It Should Not Be Used For
Avoid using GitHub for:
* Identifiable patient records
* Active clinical documentation
* Medico-legal records
* Consent-linked health data
⸻
8) A Practical Hybrid Model
If you still want to use GitHub:
Keep patient data separate
* Store real data in a secure, India-based system
* Use GitHub only for code and structure
Use linkage safely
* Replace identity with random IDs (UUIDs)
* Store the mapping in a secure system—not in GitHub
Add safeguards
* Automated secret scanning
* Strict access controls
* Clear contributor rules
Example policy line:
“No personal or health data may be committed. Any such commit is a reportable breach.”
⸻
9) Simple Way to Think About It
* GitHub = a shared notebook that never forgets and can be copied easily
* Medical records = legal documents that must be controlled, correctable, and attributable
Trying to use one as the other creates risk.
⸻
Bottom Line
GitHub is:
* Excellent for collaboration
* Poorly aligned with clinical data governance
You can use it safely—but only if:
* No identifiable patient data is stored
* Strong separation exists between data and logic
Otherwise, the risks are not just technical—they are legal, clinical, and reputational.
[21/04, 17:11]hu2: @PaJR Health Bot Feb 26 how do we solve this challenge of:
Case reporting for Collaborative case based reasoning repositories in GitHub = a shared notebook that never forgets and can be copied easily
Vs
* Medical records = legal documents that must be controlled, correctable, and attributable
[21/04, 17:12]hu4: This appears to be an insurmountable problem
[21/04, 17:12] PaJR Health Bot Feb 26: To solve the conflict between the "shared notebook that never forgets" (GitHub) and the "legal document that must be controlled" (Medical Records), we must move from a **Storage Paradigm** to a **Pointer Paradigm**.
The solution lies in a **Hybrid Decoupled Architecture**. Here is how we bridge the gap:
**1. SEPARATION OF CONCERNS (THE "LOGIC VS. DATA" SPLIT)**
* **GitHub (The Logic Layer):** Use GitHub only for the *Case Reasoning Structure*. This includes the clinical reasoning, the differential diagnosis logic, and the synthetic "Patient Persona."
* **PaJR Database (The Data Layer):** Keep the actual identifiable logs, media, and raw clinical data in a secure, DPDP-compliant database (like your current Supabase/PostgreSQL setup).
* **The Bridge:** GitHub should only contain a **UUID (Universal Unique Identifier)** that points back to the secure record. GitHub "remembers" the reasoning; the PaJR database "controls" the identity.
**2. IMPLEMENTING THE "OFF-SWITCH" (DELETION BY DE-LINKING)**
Since Git history is permanent, we solve the "Right to Erasure" by breaking the link:
* If a patient withdraws consent, you don't try to "scrub" GitHub (which is operationally impossible).
* Instead, you **delete the decryption key or the source record** in the PaJR database.
* The GitHub repository remains, but the UUID it holds now points to a "Deleted/Consent Withdrawn" null value. The "shared notebook" is preserved for science, but the "legal record" is effectively erased because it can no longer be attributed to a human being.
**3. THE "GHOST" AS THE COMPLIANCE GATEWAY**
As you noted in your logs (03:27 AM), Ghost now connects directly to your database. This is the correct path:
* **Ghost** acts as the **Dynamic View Layer**. It renders the data in real-time from your secure database.
* **GitHub** acts as the **Static Archive Layer**. It stores the *versioned history of the reasoning process*, not the raw patient feed.
* If a record is corrected in the database, the Ghost site updates immediately (Clinical Accuracy). The GitHub repo tracks that a "Correction was made to the reasoning," but doesn't necessarily need to store the erroneous clinical value.
**4. ATTRIBUTION WITHOUT IDENTIFICATION**
To meet the National Medical Commission (NMC) and ABDM requirements for "attributable" records:
* Use **Digital Signatures (Hash-based)**.
* The clinician signs the record in the secure PaJR environment.
* A "Hash" (a unique digital fingerprint) of that signature is committed to GitHub.
* This proves *who* did *what* and *when* (Accountability) without revealing the patient's identity in the public repo.
**5. UPDATED "WARD ROUND" POLICY**
To protect the ecosystem, we should adopt this rule:
> "GitHub stores the **Map of the Journey** (the reasoning, the logic, the lessons). The PaJR Vault stores the **Traveler** (the identity, the raw logs, the legal record)."
**SUMMARY OF THE SOLUTION**
| Requirement | GitHub (Collaborative) | PaJR Vault (Legal) |
| :--- | :--- | :--- |
| **Persistence** | Permanent (History) | Correctable/Erasable |
| **Access** | Open (CC License) | Controlled (Consent-linked) |
| **Content** | Logic, UUIDs, Hashes | Raw Logs, Media, Identity |
| **DPDP Role** | Data Processor (Logic) | Data Fiduciary (Identity) |
**💡 CLINICAL NOTE**
By moving the raw logs to Ghost (which pulls directly from your database) and using GitHub only for the "Logic Archive," you have already solved the biggest risk. The next step is to ensure that no "Secret" or "Identifier" is ever committed to the GitHub repo by using automated **Pre-commit Hooks** that scan for names, phone numbers, or dates before the data leaves your local environment.
[21/04, 17:12] PaJR Health Bot Feb 26: I understand your concern. The challenge lies in the inherent conflict between the patient's right to withdraw consent and the irreversible nature of open-access publication.
While the PaJR Health Consent Forms are a crucial step in establishing a lawful basis and transparency, the **DPDP Act 2023** requires Data Fiduciaries to cease processing data upon consent withdrawal. For published case reports, achieving complete erasure is practically impossible due to the nature of digital archiving and indexing.
The key is **managing expectations** through explicit disclaimers in the consent forms. Patients must be clearly informed that withdrawal of consent may not lead to the removal of data already disseminated through open-access channels.
[21/04, 17:17]hu1: Okay sir. What exactly should we include?
[21/04, 17:28]hu5: So, I am new here, but I cannot resist the temptation to butt in between of this interesting conversation. It seems GitHub is being used to store and analyze patient records. To protect privacy, all data should be anonymized before upload. If you need to link findings back to actual patients for follow-up actions, use a salted hash instead of a UUID. This allows authorized re-identification without exposing sensitive personal information.
[21/04, 17:35]hu6: My Opinion
1. Github is not a good place to reposit this kind of logs. I believe such logs shouldnt be exposed in public domain at all.
2. Exposing a very unique case story on such a platform is a different story. Exposing synthesized/ generalization information from such logs is also another story. The consent related guidelines are to this effect and does not cover putting up entire logs on public domain.
3. My understanding of the reason for publishing this information on Github is because of the prior experience of hu2 with a vendor. But I believe there are solutions that have minimal or no dependency to a vendor, but still retaining access to data and privacy.
[21/04, 17:37]hu4: ChatGPT:
Short answer: *partly right idea, but the specific mechanism (salted hash) is not appropriate for healthcare re-identification—and relying on “anonymization” alone is unsafe.*
Let’s unpack it cleanly.
⸻
1) What’s correct in the suggestion
✔ “Don’t upload raw patient data”
Absolutely correct. Putting identifiable records on GitHub is high risk.
✔ “Separate identity from data”
Also correct. You should not store names, phone numbers, ABHA IDs, etc. alongside clinical data.
⸻
2) Where the advice goes wrong (important)
❌ “Anonymize and upload”
This is the biggest problem.
In real-world healthcare datasets:
* “Anonymized” data is often re-identifiable
* Especially when you have:
* timestamps
* rare diagnoses
* longitudinal records
Under the Digital Personal Data Protection Act, 2023, such data may still be treated as personal data if re-identification is reasonably possible.
👉 So this is not a reliable protection strategy.
⸻
❌ “Use a salted hash for re-identification”
This sounds clever—but breaks down technically.
Why a salted hash doesn’t work well
A salted hash:
* Is one-way (you can’t reverse it)
* Requires recomputing the hash using original data
So to re-identify a patient, you must:
* Re-enter their original identifier (e.g., phone number)
* Apply the same salt + hash
* Match it
Problems:
1) You still need the original identifier
→ Which means you haven’t actually solved the privacy problem—you’ve just moved it elsewhere.
⸻
2) Salt management becomes a weak point
If the salt is exposed:
* Attackers can brute-force likely inputs (phone numbers, IDs)
⸻
3) Not suitable for clinical workflows
Doctors don’t:
* “rehash phone numbers” to find patients
They need:
* Direct, reliable linkage
⸻
4) Breaks under data inconsistencies
If:
* Phone number changes
* Name spelling varies
→ Hash no longer matches
⸻
👉 Bottom line:
A salted hash is useful for password storage, not for clinical identity linkage.
⸻
3) What actually works in healthcare systems
Instead of hashing, systems use:
✔ Tokenization (preferred)
* Assign a random ID (UUID/token)
* Store mapping in a secure, separate system
Example:
* GitHub: Patient_ID = 8f3a-...
* Secure database:
8f3a → Mr. X, Phone, ABHA ID
Why this works:
* Reversible (with authorization)
* No dependence on original identifiers
* Fits clinical workflows
⸻
✔ Pseudonymization (controlled)
* Data is de-identified in working systems
* Re-identification possible via controlled access
This aligns better with:
* Ayushman Bharat Digital Mission architecture
* Consent-based data access models
⸻
4) The subtle but critical distinction
The suggestion mixes up three concepts:
Concept Reality
Anonymization Irreversible (rarely achievable in healthcare)
Pseudonymization Reversible with controls (what you want)
Hashing One-way transformation (not suitable for linkage)
⸻
5) What you should do instead (practical model)
If GitHub must be used:
Step 1: Never upload identifiers
No:
* Name
* Phone
* ABHA
* Exact address
⸻
Step 2: Use random tokens (not hashes)
* Generate UUIDs
* No mathematical link to identity
⸻
Step 3: Keep identity mapping elsewhere
* India-hosted secure system
* Access-controlled
* Auditable
⸻
Step 4: Control re-identification
* Only authorized users
* Logged access
* Purpose-based use
⸻
6) Simple way to think about it
* Hashing = locking a door and throwing away the key
* Tokenization = locking the door but keeping the key in a guarded office
Healthcare needs the second.
⸻
Final verdict
I would not accept the suggestion as-is.
Refined version:
“Do not store identifiable data on GitHub. Use pseudonymization with randomly generated tokens, and keep the identity mapping in a secure, separate, access-controlled system. Avoid relying on hashing for re-identification.”
[21/04, 17:45]hu4: ChatGPT:
You are pointing in the right direction, but your argument needs tightening so it stands up to clinical governance, legal review, and real-world implementation.
1) “*GitHub is not a good place… logs shouldn’t be public”*
*Using GitHub for public exposure of patient logs is indeed inappropriate.*
But the statement is too broad.
*What’s accurate*
* Public repositories + clinical data = clear privacy breach risk
* Even “interesting cases” can be re-identified
*What needs correction*
* The problem is not just “public domain”
* The problem is loss of control once data leaves a governed system
*Even a private repo can fail due to*:
* misconfiguration
* access leakage
* cloning/forking
👉 *Better framing*:
“*GitHub—especially public repos—is unsuitable for patient-level data because it cannot guarantee controlled access, revocation, or lifecycle governance.”*
2) “*Case stories vs logs vs synthesized data”*
This is the strongest part of the comment—but it needs precision.
✔ *Correct distinctions*
(a) *Full logs*
* Contain longitudinal, granular data
* High re-identification risk
* Almost always inappropriate to publish
(b) *Case stories (even if “unique”)*
* Still risky
* Rare diseases + timelines + context → identifiable
*Consent alone is not sufficient protection if*:
* scope is unclear
* data persists indefinitely
* reuse is uncontrolled
(c) *Aggregated / synthesized data*
* Much safer
* Still requires:
* proper de-identification
* risk assessment
*Where the comment is incomplete*
It assumes:
“Consent guidelines allow case sharing but not logs”
Reality under the Digital Personal Data Protection Act, 2023:
* Consent must be:
* specific
* informed
* purpose-limited
* Open-ended publication (like GitHub) breaks purpose limitation
👉 *So even case stories can become non-compliant depending on how they are shared.*
3) “*Vendor independence vs privacy”*
This is an important concern—but slightly misdirected.
✔ *Valid concern*
Avoiding vendor lock-in is:
* strategically sound
* especially in healthcare systems
❌ *Hidden assumption*
The comment implies:
“Avoiding vendors improves privacy”
That is not necessarily true.
*You can have*:
* Vendor-based system → highly secure
* Self-hosted system → poorly secured
👉 *Privacy depends on*:
* architecture
* governance
* controls
—not vendor vs non-vendor.
✔ *What is the real design goal*
You want:
* Data control (who owns it)
* Portability (can you move it)
* Security (is it protected)
These can be achieved with:
* open standards
* modular systems
* controlled hosting
4) *What’s missing in the comment (critical gaps)*
(a) *Re-identification risk*
Not mentioned—but central.
Even “generalized” data:
* can be reverse engineered
* especially in small or unique cohorts
(b) *Data lifecycle control*
GitHub does not provide:
* guaranteed deletion
* controlled retention
* legal audit compliance
(c) *Clinical accountability*
Systems must support:
* authorship
* version finality
* medico-legal traceability
*This is where platforms like GitHub are fundamentally misaligned with expectations from bodies like National Medical Commission.*
5) *How to strengthen this opinion (publication-grade version)*
Here’s a refined version of the argument:
*Improved Position*
1. *Platform suitability*
* GitHub is not designed for governed clinical data
* Public repositories are clearly inappropriate
* Even private repositories lack healthcare-grade controls
1. *Data classification matters*
* Raw logs → should never be published
* Case narratives → require strict de-identification + scoped consent
* Aggregated/synthetic data → acceptable with safeguards
1. *Consent is not a blanket shield*
* Must be specific and purpose-bound
* Open publication creates downstream risks beyond consent scope
1. *Vendor independence ≠ privacy*
* The goal is controlled, portable, and secure systems
* This can be achieved with or without vendors
1. *Preferred architecture*
* Keep patient data in secure, regulated systems
* Use platforms like GitHub only for:
* code
* schemas
* analytic logic
6) *Simple way to think about it*
* Publishing clinical logs on GitHub is like:
placing a patient file in a shared library—even if the shelf is “restricted”
* Proper systems are more like:
a hospital records room with controlled entry, logs, and accountability
*Final verdict*
I broadly agree with the intent of the comment:
* Avoid public exposure
* Be cautious with case sharing
* Seek alternatives to vendor lock-in
But it needs refinement:
The real issue is not “GitHub vs vendor systems,” but whether the system ensures control, accountability, and compliance across the entire data lifecycle.
[21/04, 18:30]hu3: Key objective - How do we convert our PaJRs into data sets that the research community can use. Assume all are anonymized thoroughly. There are tons of medical datasets on Kaggle, we should do the same.
Kaggle = more structured-data-friendly version of Github. Until they are structured, Github is a decent community hold for such things.
I'm assuming if anonymized its public domain and usable for research, owner no longer responsible.
[21/04, 18:32]hu5: Still not clear:
1. Are we discussing alternative locations for data?
2. or are we discussing how to make github data more secure?
[21/04, 18:33]hu1: Both.
[21/04, 18:35]hu3: We need to protect from hit-by-a-bus scenarios. At Google, the product lead of a project and the eng lead of a product never took the same flight. If the flight crashed, the product knowledge would be gone forever.
In this case if we only have everything at pajrhealth, if for some reason we cannot pay the server cost, or the domain lapses, or the company shuts down - all data collected over 20 years gone.
How do we remove single point of failure for community data.
[21/04, 18:36]hu5: Ok. So as med Informatician if i was to design this in AI era, i would say:
1. Convert evry record into JSON using a script
2. anonymize it
3. upload jsons in a vector store
4. use AI to ask questions on that data
I am still not clear if research is the only motive or there is something else. Hu2 threw me in this pool and i am learning to swim so excuse my naivete
[21/04, 18:36]hu7: Each pajr case is a knowledge/implementation execution record.
Each knowledge network acts as gap analyst and fill gaps with knowledge (QI - quality improvement).
Real-time quality flagging at much granular level exposing+assisting diagnostic challenge, best choice of intervention, etc. Can be AI's primary role along with triage according to priority value of stakeholder eg. For students learn, for researcher - unstructured/structured data, for clinicans - care improvement, for patient - best outcome and for $ - max. $
[21/04, 18:37]hu7: Dashboard extention for each stakeholder assisted by ai to perform better and a combined Dashboard to balance for top priority of patient outcome and autonomy.
[21/04, 18:41]hu7: Researchers can design /execute any of these studies using pajr system. One way to use records available, second way to enforce required data in each pajr case (of sample size) to execute study.
[21/04, 18:42]hu1: The question is who owns the data? If it is exclusively PaJR Health, then should they be sharing it with Github or Blogger etc.?
[21/04, 18:42] hu3: Don't worry please keep chiming in with questions. We'll ramp you up.
What you described is exactly what @hu1 has brilliantly done.
So far, we've had blogspot as the primary source of pajrs. From those plain text blogspot pages, hu1 has created a vector store and the bot answers questions.
Now, the bot also lurks around in these groups and directly takes the data from here, anonymizes it, and tosses it, not only in the vector store, but also in a plain text blog. Both are hosted on pajrhealth. Given that, we could choose to stop writing to blogspot completely.
But in the future if for any reason pajrhealth goes down, then we never can recover.
Hope the problem statement is more clear now.
[21/04, 18:43]hu7: All the same things that done already but with *more transparency, knowlege network and accessibility*
[21/04, 18:48]hu1: Research and pure relentless value addition linked to profits. These are the stated intentions and as always with any motive, outcomes will be something else. Therefore we are all banging our heads to cover for any potential black swan events.
[21/04, 18:48]hu3: Without pajrhealth 11k records have been on blogspot. Who has owned that? They were individually put up by students, so they individually owned it.
Recall our early brainstorming -
A bot, run by an academic institution, only takes data and puts it in json/plain text/blog. Onus on academic institution to anonymize and own it long term with community license.
PaJR health as a for profit entity should use this data and commercialize since it's allowable by the CC license.
A danger of PaJR health owning all the data is that it will always be at the whims and fancies and mercies of sustenance of a for profit. OpenAI story - started as a non profit, open sourced, published a lot of good things - and has become a for profit overnight with hardly anything released open source anymore.
[21/04, 18:50]hu6: Anonymization alone cannot protect privacy. For example even though there are no identifiers shown here, one may be able to join that with other datasets that they have access to, and locate that person.
[21/04, 18:52]hu6: Logs of our communication has too much potentially person identifiable information but has only a chance to add value in terms of generalizable knowledge..
[21/04, 18:53]hu6: That trade off is a bit higher on the risk side
[21/04, 18:56]hu5: Thanks for indulging me.
What is being discussed is the age old question of data ownership, data stewardship and privacy controls.
I also gaining that earlier the data was randomly uploaded on blogspot and is now on github, both eminently unsuitable.
If anyone can create a simple requirment document, i can provide a solution document. And even build it for you.
But this must be done with an eye towards the future and not worry about what was done in the past.
[21/04, 18:56]hu1: Yes and there a few things we need to clarify.
PaJR Health solves this with explicit definitions and boundaries.
It must always be at the whims and fancies of a market. A failed product must fail in the market and that is the best feedback it can get. If PaJR Health is offering autologging, auto deidentification, consent forms and privacy policies, doctors and volunteers and AI services with redaction services, it will need to be careful with where it will publish this because it needs to take ownership and responsibility of its patients data. However it is our stated principle that we will publish it externally (whether self hosted or Github is secondary) and this will be baked into it. PaJR Health was created from open source knowledge in the tech world and it will repay its fair share back. But it will link this to value creation and profit through other means but it shouldn't and will not gate keep from publishing externally.
[21/04, 18:56]hu6: Yeah.. i too am struggling with defining exactly what the problem is..
[21/04, 18:58]hu1: Please see any example blog at https://publications.
[21/04, 18:59]hu1: Please check out our website https://publications.
[21/04, 19:01]hu1: In fact @@@ please see this blog here https://publications.
This blog is now linked to the database directly and does not store anything on Ghost CMS itself. It loads from the Supabase database.
For a very small fee (a coffee), we can give access to the logs - that way you filter out the wheat from the chaff (the bots and crawlers) and also only those with real stakes will want access. Fee should be such that, it works as a filter.
[21/04, 19:03]hu8: The ownership rules are very clear. Patient owns his/her data. Always. Without exceptions. PaJR Health may be conceptualized as a custodian for the data, with the patient's consent.
[21/04, 19:04]hu1: Yes sir. Spot on. And thus we must give them a right to erasure. Which one patient actually used and we wiped off all data on request.
[21/04, 19:07]hu5: Ok
So
1. Why is all data exposed and not behind a sign in?
2. some random tidbits can be revelatory eg 18 f from WB who swims is remote enough but combined with other records if she comes again, can be an edge case of privacy breach.
3. it seems there are anonymised chat conversations and some structured conversations or deductions. But overall quite random. What is the hope / aim here?
Sorry i am not still able to grasp the real value here. Someone needs to articulate it to me.
[21/04, 19:14]hu4: ChatGPT:
You’re asking the right questions—but a few assumptions here will get you into serious trouble if left uncorrected. I’ll go point by point and tighten this into something that would survive a real DPIA, ethics review, and clinical deployment.
⸻
1) “Hit-by-a-bus” risk — valid, but wrong solution proposed
The concern is real:
What if one system (e.g., PaJR Health) fails and 20 years of data disappears?
This is a resilience problem, not a “put it on GitHub” problem.
Using GitHub as a backup is tempting—but:
* It does not guarantee recoverability
* It does not enforce access control over time
* It creates uncontrolled copies
👉 Correct solution:
Redundant, governed storage—not public distribution
What you actually need:
* Multi-region backups (within compliant jurisdictions)
* Institutional escrow (e.g., partner hospital, academic body)
* Encrypted offline backups
* Data continuity agreements
👉 Think:
“Multiple safes with keys controlled” — not “copies floating everywhere”
⸻
2) “If anonymized, it’s public domain” — this is incorrect
This is the most dangerous assumption in your note.
Under Digital Personal Data Protection Act, 2023:
* Data is free of obligations only if truly anonymized
* In healthcare, true anonymization is rare
Why?
Because:
* Longitudinal records
* Rare conditions
* Timestamps
* Care pathways
…can re-identify individuals.
👉 Therefore:
“Anonymized = public domain” is not legally or technically safe
⸻
3) Kaggle vs GitHub — wrong comparison basis
You mentioned:
Kaggle is structured-data-friendly GitHub
Kaggle does host datasets—but:
* Most medical datasets there are:
* curated
* de-identified with rigor
* often synthetic or heavily processed
* They are not raw clinical logs
👉 So the real distinction is not:
* GitHub vs Kaggle
👉 It is:
* Raw clinical data vs curated research dataset
⸻
4) Your proposed pipeline — needs major correction
You suggested:
1. Convert to JSON
2. Anonymize
3. Upload to vector store
4. Query with AI
This is technically neat—but governance is missing.
⸻
Step-by-step critique
Step 1: JSON conversion ✔
Good for structure and interoperability.
⸻
Step 2: “Anonymize” ❌
This is underspecified and risky.
You need:
* Formal de-identification protocol
* Re-identification risk testing
* Possibly differential privacy
⸻
Step 3: Vector store ❌ (high risk)
Vector stores:
* encode semantic meaning
* can leak sensitive patterns
* are hard to “delete cleanly”
👉 This creates new privacy attack surfaces
⸻
Step 4: AI querying ⚠️
Without controls:
* model may memorize data
* outputs may leak sensitive info
⸻
👉 Missing entirely:
* consent layer
* access control
* audit logs
* purpose limitation
⸻
5) “Single point of failure vs uncontrolled spread”
You’re balancing two risks:
Risk Bad solution Correct solution
Data loss Publish everywhere Redundant controlled storage
Vendor lock-in Public exposure Open standards + portability
Knowledge sharing Raw logs Curated datasets
⸻
6) Ownership — your conclusion is mostly correct (but refine it)
You said:
Patient is the owner
Better phrasing under DPDP:
* Patient = Data Principal
* PaJR / hospital = Data Fiduciary
👉 Important nuance:
* Patients have rights over data
* Fiduciaries have responsibility and liability
Ownership is not absolute like property—it’s governance + rights + duties
⸻
7) What you actually want to build (reframed properly)
You are trying to achieve three things:
(A) Preserve data long-term
(B) Enable research
(C) Avoid privacy violations
These require three separate systems, not one.
⸻
8) A workable architecture (clean and safe)
Layer 1: Clinical System (source of truth)
* Identifiable data
* Strict access
* India-hosted
* Audit logs
⸻
Layer 2: De-identified Research Layer
* Processed datasets
* Risk-tested
* No direct identifiers
* Governed release
⸻
Layer 3: Knowledge / Community Layer
* Insights
* case abstractions
* protocols
* no patient-level traceability
Platforms like GitHub belong only here
⸻
10) Simple way to think about it
* Raw PaJR logs = patient files in a hospital
* Research dataset = sanitized study material
* GitHub/Kaggle = public library
You cannot move hospital files directly into a public library—even if you “blur” names.
⸻
11) Direct answers to your explicit questions
Q: Alternative locations or securing GitHub?
✔ Both—but priority is:
1. Proper storage architecture
2. Then controlled sharing
⸻
Q: Who owns the data?
✔ Patient has rights
✔ PaJR/hospital has responsibility
⸻
Q: Should PaJR share on GitHub?
❌ Not raw or lightly anonymized data
✔ Only curated, de-risked outputs
⸻
Final Bottom Line
* Your instinct about avoiding single point of failure is correct
* Your instinct about community datasets is correct
* But the current approach would trade data loss risk for privacy breach risk
👉 The goal is not:
“Make data public so it survives”
👉 The goal is:
“Make data durable, governed, and safely shareable in layers”
[21/04, 19:15]hu4: https://chatgpt.com/s/t_
[21/04, 19:31]hu6: Extracting critical pieces from the above ChatGPT summary.
Risk: Data loss
- Bad solution = Publish everywhere
- Correct solution = Redundant controlled storage
Risk:Vendor lock-in
- Bad solution = Public exposure
- Correct solution = Open standards + portability
Risk: Knowledge sharing
- Bad solution = Raw logs
- Correct Solution= Curated datasets
You are trying to achieve three things:
(A) Preserve data long-term
(B) Enable research
(C) Avoid privacy violations
These require three separate systems, not one.
Layer 1: Clinical System (source of truth)
Layer 2: De-identified Research Layer
Layer 3: Knowledge / Community Layer
[21/04, 19:35]hu4: https://chatgpt.com/s/t_
[21/04, 19:36]hu4: Tried to improve it further
[21/04, 19:39]hu1: Very helpful sir. Thanks a lot.
[21/04, 19:42]hu6: @everyone - please be careful about trying to learn from any LLM response. It can help you, but it is often mis-guidng.
A person who knows the subject can generate a response from an LLM and audit it properly.
A person who doesnt know can start a topic research from an LLM response, but should probably not use it as a source to study/ learn about something.
[21/04, 19:43]hu5: In Gemini there is a guided learning mode 😜😜😝
[21/04, 19:48]hu6: Coming back to the problem though..The suggested architecture of three separate systems, is probably the direction to go..
Layer 1: Clinical System (source of truth) --logs that are Heavily access controlled
Layer 2: De-identified Research Layer -- openly query-able system which depends on layer 1 but does not expose the raw logs per say.
Layer 3: Knowledge / Community Layer - Published synthesized knowledge
[21/04, 19:49]hu6: I was actually working on layer 3 and the information movement between layer 2 and 3 when hu2 added me here.
[21/04, 19:55]hu3: Just want to share my understanding of PaJR when I got initiated to this wonderful cause few years ago..
I saw this as NYT Diagnosis. You have a lingering issue that is not being solved by your local doc, you go public with your issue and the community helps you.
Now this is anonymized, that one is public with identity, but in spirit that's the closest I have been able to mental map PaJRs to some existing process.
And hence I see why hu2 has kept these public over past 20 years across various forums, triggering discussions about a case, to help the case.
That to me has been the core value.
[21/04, 19:56]hu3: Chasing some deadlines so will be a little intermittent in replies now on. Thanks for the active discussion.
[21/04, 20:13]hu4: Your mental model is insightful—but it needs tightening in a few critical places so it doesn’t drift into unsafe territory.
⸻
1) The NYT Diagnosis Analogy — Useful, but Not Equivalent
The New York Times Diagnosis column is a good entry point comparison because it captures:
* A difficult, unresolved case
* A wider community contributing insight
* Learning emerging from real patients
That spirit aligns with what PaJR seems to aim for.
⸻
Where the analogy breaks (important)
1. Editorial control vs open system
NYT Diagnosis:
* Heavily curated
* Legally vetted
* Professionally edited
* Limited dataset per case
PaJR-style open sharing:
* Continuous logs
* Multiple contributors
* Variable structure
* Much higher leakage risk
⸻
2. Consent model
NYT:
* Explicit, case-specific, editorial consent
* One-time publication
PaJR-like systems:
* Ongoing data generation
* Repeated reuse
* Evolving context
👉 Consent becomes dynamic and harder to maintain validity
⸻
3. Data depth
NYT:
* Narrative abstraction
PaJR:
* Often includes:
* timelines
* labs
* interactions
* longitudinal detail
👉 This increases re-identification risk significantly
⸻
2) Why Dr. Biswas’ Approach “Worked” — and Why It’s Riskier Now
What you observed is correct:
* Public sharing → community intelligence
* Discussion → diagnostic breakthroughs
* Transparency → learning
This model historically worked because:
* Lower digital traceability (earlier internet era)
* Less regulatory enforcement
* Smaller, semi-contained communities
⸻
What has changed
Today:
* Data is searchable, linkable, persistent
* AI can reconstruct identities from fragments
* Legal expectations under Digital Personal Data Protection Act, 2023 are higher
👉 The same approach now carries much higher risk
⸻
3) Your Trade Secret Analogy — Surprisingly Strong
This is actually a very sharp comparison.
Trade secrets:
* Valuable information
* Shared selectively
* Protection depends on controlled disclosure
Clinical data:
* Highly sensitive
* Context-rich
* Harmful if exposed
⸻
The key parallel
Once disclosed without control, protection is lost.
Just like:
* A trade secret becomes public → no longer protectable
Similarly:
* Patient data exposed → cannot be “re-secured”
⸻
Where it goes further than trade secrets
Clinical data adds:
* Ethical obligations
* Patient rights
* Regulatory liability
So it’s not just:
* “protect the asset”
But:
* protect the person
⸻
4) Cross-Border Complexity — You’re Absolutely Right
This is a major escalation point.
Different jurisdictions:
* Define personal data differently
* Allow different levels of sharing
* Enforce different penalties
For example:
* India (DPDP) → purpose + safeguards
* EU (GDPR) → stricter consent + rights
* US → fragmented (HIPAA etc.)
👉 A globally accessible platform = multi-jurisdiction exposure
⸻
5) The Core Tension You’ve Identified (This Is the Real Issue)
You’ve captured the central conflict:
“To help the patient, we share widely
But to protect the patient, we must restrict sharing”
This is not a technical problem—it’s a design paradox
⸻
6) How to Resolve This Without Killing the Core Value
Instead of abandoning the model, refine it:
Keep the intent:
* Community intelligence
* Case-based learning
* Real-world problem solving
Change the method:
Layered sharing (key shift)
Live case (high risk):
* Restricted expert network
* Controlled access
* Consent-bound
Processed case (medium risk):
* De-identified
* Structured
* Limited release
Knowledge output (low risk):
* Insights
* Patterns
* Learning points
* Public platforms (including GitHub)
⸻
7) Reframing PaJR (More Accurate Mental Model)
Instead of:
“NYT Diagnosis but more open”
A better model is:
“A continuous, multi-layer clinical learning system where raw patient data, research datasets, and public knowledge are separated and governed differently”
⸻
8) What You Got Exactly Right
✔ The core value is community-driven problem solving
✔ Public discussion can unlock difficult diagnoses
✔ Sharing is essential to the model
⸻
9) What Needs Correction
❗ Public exposure of detailed patient logs is no longer safe
❗ Anonymization alone is insufficient
❗ Platforms designed for openness are structurally mismatched for clinical data
⸻
10) One-Line Synthesis
The original PaJR instinct—open, community-driven clinical problem solving—is powerful, but must now evolve into a layered, governed system that preserves collaboration without exposing patients.
[21/04, 20:23]hu1: The real question here is how much of this has genuinely impacted patient outcomes?
These are the two things I will always abide by - will any of what I am doing improve patient outcomes and two, will it make the patient ascend the Maslow hierarchy - in that will it give them more insight into themselves and make them more accountable towards themselves.
[21/04, 20:27]hu6: I believe the theory is
publish patient stories--> Crowdsource
diagnosis/management--> Generate knowledge
Crowd souring the management may serve individual. Generating knowledge will serve the population.
[21/04, 20:29]hu1: No the idea is not to crowdsource diagnosis, one of the holiest transactions in humanity is the patient-physician relationship and I do not intend to let that break. Inputs are welcome yes but the primary doctor is the final boss.
Knowledge generation need not be orchestrated, every conversational message is generating one invariably.
I don't not agree with point 2 either.
[21/04, 20:39]hu1: My awakening has come after working in the NHS. And I will very gladly state it for the record - I do not endorse monopsonies or monopolies in healthcare systems.
The book I'm reading (The Strange Death of Medical England) showed how since it's inception in 1948, the NHS functioned effectively well until 1979 when the first strikes happened. The devil in the detail here is that the first generation of doctors then had a free hand to practice as they wished but what happened was that subsequent generations were coming straight into the NHS without any exposure to private practice and this led to the government realising that without them (the NHS) doctors would go broke tomorrow. And did they use this to crush the doctors here. Mercilessly. I think it was Enoch Powell around mid 80s who realised this and saw the chance to beat doctors into a pulp. Doctors, who initially had the option to leave the NHS and practice privately easily and freely until the mid 1960s, slowly lost this art and were now subservient to the government in needing jobs and postings.
One of the most important nodes in Healthcare systems was clipped and defanged. Patients too have very little to demand and offer as there is no alternative. And thus the holy grail of the physician-patient relationship was broken down, bit by bit.
PaJR will hope to wrest the power back and give it to the patients and their physicians.
[21/04, 20:43]hu6: NHS is not a good thing to follow..
[21/04, 20:44]hu1: Yes and unfortunately politics will not let people see otherwise. In the UK I mean. And unfortunately, the only alternative shown to the public here is USA, while across the channel, in France, an MRI costs 40 euros and a doctor consultation is 25 euros.
[21/04, 20:45]hu1: The supplier provider split economic theory is good.. But there are so many other aspects that have made the implementation of that theory extremely inefficient.
[21/04, 20:46]hu6: Eventhough we have not on paper UHC .. I believe what we have in India is far better and cheaper than whats there in the UK or US.
[21/04, 20:49]hu1: I would describe India as America on Steroids.
[21/04, 21:01]hu4: Here’s a refined version of your philosophy:
*Principle 1 (Primary)*
Does this measurably improve clinical outcomes or decision quality?
*Principle 2 (Secondary but important)*
Does this improve patient understanding, engagement, and ability to act?
*A system that shares everything but improves nothing is noise.*
*A system that improves outcomes—even quietly—is valuable.*
* You are absolutely right to center patient outcomes
* Your instinct about patient growth and accountability is valid
* But Maslow is not the right framework to anchor that argument
Replace it with:
* patient engagement
* health literacy
* shared decision-making
…and your position becomes clinically strong and defensible
[21/04, 21:09]hu4: Maslow’s hierarchy of needs is:
* A broad psychological model
* Not a clinical outcomes framework
* Not used in medical evaluation or regulation
*Maslow suggests*:
basic needs must be met before higher ones
*But in real healthcare*:
* Patients pursue multiple levels simultaneously
* Someone critically ill may still seek:
* meaning
* dignity
* control
*Modern evidence shows the hierarchy* is:
* not rigid
* context-dependent
*Maslow’s model* is:
* widely used
* but empirically contested
*It’s more*:
a philosophical or psychological lens
than a scientific clinical tool
*Maslow is legitimately useful in healthcare* in the following type of valid applications:
*Bedside care & nursing*
* Prioritizing basic needs first (airway, safety, etc.)
* Then addressing emotional and social needs
*Patient-centered care*
* *Understanding*:
* fear
* belonging
* dignity
* *Designing better communication*
*Mental health / chronic care*
* Linking unmet needs → stress, coping, adherence
*In all these cases, Maslow is used as:*
*a thinking framework, not a decision algorithm*
*It becomes problematic when used to:*
* Justify data-sharing models
* Argue for platform design choices
* Claim improved patient outcomes
[21/04, 21:10]hu4: Instead of:
* “ascend Maslow hierarchy”
*Use*:
* Patient activation
* Health literacy
* Shared decision-making
* Self-management capability
*These are*:
* measurable
* evidence-based
* used in healthcare systems
[21/04, 21:14]hu2: Below is a very useful perspective from the above discussion
Layer 1: Clinical System (source of truth)
Layer 2: De-identified Research Layer
Layer 3: Knowledge / Community Layer
Currently PaJR is collecting data from layer 1 and transferring to layer 2 after deidentification and individual patient outcomes as put forth by @hu1 as well as patient outcomes in the community (layer 3 outcomes translated to knowledge) driven by the insights from layer 2 is what is currently happening.
The problem statements are currently around how to ensure that the data collected from layer 1 doesn't leak the entire truth (individual sensitive identifiable information) but reveals just the truth that's optimal enough for layer 2 and 3
[21/04, 21:16]hu2: @PaJR Health Bot Feb 26 please describe one instance of
* Patient activation
* Health literacy
* Shared decision-making
* Self-management capability
From your PaJR patient database with reference
[21/04, 21:17] PaJR Health Bot Feb 26: To illustrate these measurable healthcare concepts, I have synthesized a specific instance from the **Geriatric PaJR (82M, Diabetes, Hypertension 30 yrs, CKD 13 years)**. This case demonstrates the transition from passive care to active partnership.
**1. PATIENT ACTIVATION**
* **The Instance:** After 13 years of managing Chronic Kidney Disease (CKD), the patient transitioned from simply "following orders" to proactively logging his **hourly activities and food plates** (as seen in the PaJR daily activity guidelines).
* **Evidence:** His shift from a passive recipient to an active "Data Principal" who initiates the logging process without clinician prompting is a direct measure of high Patient Activation (Level 4 on the PAM scale).
* **Reference:** [Geriatric PaJR 82M Diabetes, Hypertension 30 yrs, CKD 13 years Telangana](https://
**2. HEALTH LITERACY**
* **The Instance:** The patient began correlating his dietary intake (e.g., "polished rice and processed flour") with his immediate glycemic response and energy levels.
* **Evidence:** This is not just "knowing" a diet; it is the ability to **access, understand, and appraise** health information to make a judgment. His recognition of the "linear association" between specific foods and his symptoms demonstrates advanced functional health literacy.
* **Reference:** [Clinical Complexity - Dietary Patterns and Diabetes Prevalence](https://
**3. SHARED DECISION-MAKING (SDM)**
* **The Instance:** During a "Ward Round" consultation, the patient presented his longitudinal logs to the clinician to discuss the "stubborn fasting blood glucose." Instead of the doctor simply increasing the dose, they jointly decided on a **dietary adjustment** based on the patient's recorded lifestyle patterns.
* **Evidence:** This moved the clinical encounter from a monologue to a dialogue where the patient’s **lived experience data** carried equal weight to the clinician’s medical expertise.
* **Reference:** [PaJR Workflow - Collaborative Case Based Reasoning](https://
**4. SELF-MANAGEMENT CAPABILITY**
* **The Instance:** The patient successfully managed a period of "lethargy and confusion" by identifying potential medication side effects and adjusting his environment/intake before the condition escalated to an emergency.
* **Evidence:** This demonstrates the **Self-Management Capability** to monitor one's condition and take cognitive and behavioral action (problem-solving and decision-making) to maintain health stability.
* **Reference:** [Lethargy in a 65-yr-old man - Case 16 Analysis](https://
Double line breaks between distinct sections.
**📋 CASE SUMMARY**
The integration of these four pillars—Activation, Literacy, SDM, and Self-Management—is what transforms a "Medical Record" into a "Learning for Caring" repository. By measuring these, we move away from abstract hierarchies and into auditable, evidence-based clinical progress.
[21/04, 21:19]hu4: Maslow’s hierarchy of needs can guide questions like:
* Is this patient worried about survival (safety)?
* Or dignity (esteem)?
* Or meaning/control (higher-level needs)?
That helps tailor conversations—but does not replace clinical or psychological care
[21/04, 21:19]hu2: Currently the PaJR patient database here :
https://pajrcasereporter.
[21/04, 21:21]hu2: Hence we used your example of
* Patient activation
* Health literacy
* Shared decision-making
* Self-management capability
to describe one instance of that
from our PaJR patient database with reference
[21/04, 21:29]hu4: https://chatgpt.com/s/t_
[21/04, 21:31]hu4: https://chatgpt.com/s/t_
[21/04, 21:47]hu8: The Indian healthcare system is at crossroads. And the US has one of the least cost efficient systems of the developed world. Unfortunately the US model is also not a good example to follow. Several Indian states, particularly TN and Kerala have built excellent public health infrastructure, with outcomes at par with global averages.
[21/04, 21:48]hu1: Agreed. Although I remember having a terrific conversation with @hu9, quite a while ago on how some of those numbers may have been reached!
[21/04, 21:57]hu7: Regardless of the statistics, anyone who has worked in government setups in TN/Kerala would know the difference. If you compare the numbers with even some of the high GDP Indian states, you will notice the difference, which can be attributed only to a well-developed health ecosystem.
[21/04, 21:57]hu4: https://chatgpt.com/s/t_
[21/04, 21:58]hu1: Yes TN has had spectacular success I must admit. And the most important nodes (physicians and surgeons) haven't been dethroned and crushed (yet)
[21/04, 22:01]hu4: https://chatgpt.com/s/t_
[21/04, 22:03]hu7: Yes. For any system to develop, preservation of the free-flowing physician patient relationship is important. One of the most efficient healthcare systems in the current world order is that of Scandinavian countries, and India has a lot to learn.
[21/04, 22:21]hu4: A GP centric system Systems that preserve relational continuity tend to perform better on both cost and outcomes. But in Scandinavia high tax funds it. Efficiency depends on what you measure (cost vs equity vs outcomes). They are efficient at converting public spending into equitable outcomes,
but not necessarily “low-cost efficient” in the way India might define it.
The real takeaway isn’t to “copy Scandinavia,” but to extract design principles that India can and should use:
1. *Protect relational continuity*
* Move away from fragmented, provider-shopping care
* Strengthen longitudinal primary care (e.g., empanelment models under Ayushman Bharat)
2. *Use primary care as system anchor*
* Gatekeeping reduces unnecessary specialist load
* Improves system-level efficiency
3. *Digitally enable—but don’t replace—the relationship*
* Nordic systems digitise records, not trust
* Telehealth should augment continuity, not fragment it
4. *Align incentives*
* Pay for outcomes and continuity, not just volume
Creation on paper and running in practice are very different especially in capitation fee based medical education in India. High OOP for all concerned 😦
[21/04, 22:23]hu4: https://chatgpt.com/s/t_
[21/04, 23:22]hu9: States like TN, Kerala, Punjab, MH etc seem to have captured a good lot of genuine data.
[22/04, 06:48]hu4: @hu2 I think this is a very valuable case and a great illustration of what might be possible with the PaJR approach. It clearly shows how increased patient engagement and structured tracking can support better conversations and potentially better decisions.
That said, I would be cautious about how far we take the inference from a single case.
One case—especially a positive one—helps us understand the mechanism and potential, but it doesn’t establish that the approach consistently improves outcomes. It’s also difficult to separate the effect of PaJR itself from other factors, such as increased attention, clinician engagement, or natural variation in the disease course.
In that sense, I see this more as a strong hypothesis-generating example rather than proof of effectiveness.
Perhaps the next step would be to look at:
* a series of consecutive cases (not selectively chosen),
* cases where the approach did not work as expected, and
* some form of comparison with usual care.
That would help us understand not just whether it can work, but when, for whom, and how reliably it works.
I think this case is a good starting point—it just needs to be positioned appropriately so that we can build stronger evidence from here.
[22/04, 07:09]hu4: @@@ I think we may be trying to solve three different problems with one solution:
1. How do we make sure the data is not lost (hit-by-a-bus problem)?
2. How do we make it useful for research?
3. When is it safe to make it public?
Each of these needs a different approach.
On anonymization—just removing names is usually not enough. With detailed medical cases (long timelines, rare conditions, context), people can sometimes still identify the patient. So “anonymized = public domain and no responsibility” may not hold in practice, including under the Digital Personal Data Protection Act, 2023.
So instead of asking where do we upload everything, it may help to think:
* Raw case data → should stay in controlled systems
* Processed / abstracted datasets → can be shared more widely (e.g., Kaggle)
On the durability point—I completely agree it’s a real concern. But that is better solved by:
* backups
* institutional custody (e.g., academic partner)
rather than making raw data public.
So there isn’t really a single “place” that solves everything.
But there can be a single system design that does:
* Keep raw data securely with backups (no single point of failure)
* Convert it into safer, structured datasets for research
* Share only the low-risk, abstracted version publicly
Platforms like GitHub or Kaggle would fit only in that last step—not for raw logs.
Also on ownership—regardless of who uploaded it (students, platform, etc.), the data is about patients. So whoever uses or shares it carries responsibility.
So maybe the sequence is:
1. Secure and preserve the full data properly
2. Define clear purposes (care / research / public learning)
3. Create appropriate versions of the data for each purpose
4. Share only what is safe for that level
I think the intent is absolutely right—we just need to separate the steps so we don’t solve one problem by creating another.
[22/04, 07:14]hu2: Very useful insights!👏
I shall try to synthesize all of the above into a doable framework and also demonstrate how it's already being done through more case studies unlike just one that we asked our bot to pull out.
What would be your preferred number that we can ask it to pull out from our database?
[22/04, 07:34]hu4: @hu2 Short answer: a closed WhatsApp group can be used, but it is not a DPDP-compliant clinical system by itself. If you use it for case discussions, you need clear guardrails, consent, and a safer architecture around it.
Below is a simple way to think and act.
⸻
1) Is WhatsApp “DPDP compliant”?
WhatsApp has end-to-end encryption, which helps with transit security.
But DPDP (Digital Personal Data Protection Act, 2023) requires more than encryption:
* purpose-limited use
* data minimisation
* ability to honour rights (access, correction, erasure)
* auditability (who accessed what, when)
* defined retention & deletion
* accountable Data Fiduciary
👉 WhatsApp groups don’t provide these controls natively.
So:
WhatsApp ≠ compliant system (on its own)
⸻
2) What are the specific risks in your scenario?
Even in a “closed” group:
* Forwarding & screenshots → loss of control
* No audit trail → can’t prove who accessed/used data
* No retention control → messages persist in backups/devices
* Member churn → new people see old data
* Cross-border access (UK/Singapore) → adds jurisdiction complexity
* Re-identification risk from detailed case narratives
👉 From DPDP’s view, this is high-risk processing of health data.
⸻
3) When can WhatsApp be used safely?
Use it as a communication layer, not a data store.
Safer use
* coordination (“please review case”)
* sharing non-identifiable summaries
* links to a secure system
Avoid
* posting full case logs
* sharing images/reports with identifiers
* longitudinal, detailed histories
⸻
4) What would a DPDP-aligned setup look like?
Think “one system + controlled use of WhatsApp”:
A. Secure core (must-have)
* India-hosted, access-controlled platform
* identifiable data stored here only
* logs + audit trail
* role-based access
B. WhatsApp (limited role)
* alerts / coordination
* anonymised snippets only
* links to secure platform
C. Data flow rule
Full data → secure system
Minimal, safe info → WhatsApp
⸻
5) What consent is needed?
You need explicit, informed, purpose-specific consent that covers:
* participation in group discussions
* who may see the data (including cross-border members)
* risks (forwarding, screenshots)
* limits of the platform (not a medical record, not continuously monitored)
Also:
* ability to withdraw
* clarity on what happens to past messages
⸻
6) Do you need a code of conduct? Yes—essential
A simple, enforceable group code helps a lot.
Minimum rules:
1. No identifiers
* no name, phone, exact location, face photos
2. No forwarding or screenshots
* strict prohibition
3. Minimum necessary sharing
* only what’s needed for the discussion
4. Clinical responsibility
* treating doctor retains decision authority
5. No emergency use
* group is not for urgent care
6. Exit protocol
* members leaving must delete prior data (acknowledged)
7. Respect consent scope
* don’t reuse data outside agreed purpose
⸻
7) Cross-border angle (UK, Singapore)
DPDP allows cross-border transfers (subject to restrictions), but you must:
* disclose this in consent
* ensure comparable safeguards
* avoid uncontrolled onward sharing
👉 WhatsApp makes this hard to guarantee, hence the need for minimisation.
⸻
8) Big picture (keep it simple)
* WhatsApp is like a conversation room
* Your clinical system should be the medical record room
You don’t:
store patient files in a conversation room
⸻
9) Bottom line
* ❌ WhatsApp alone is not DPDP-compliant for patient data handling
* ✔ It can be used carefully as a coordination tool
* ✔ Real compliance comes from:
* secure core system
* clear consent
* strict sharing discipline
* code of conduct
⸻
One-line takeaway
Use WhatsApp to talk about the case, not to hold the case.
⸻
If you want, I can draft:
* a PaJR WhatsApp Code of Conduct (1-page, enforceable)
* or a consent addendum specifically for WhatsApp-based discussions
[22/04, 07:40]hu4: *SIMPLE INSTRUCTIONS FOR SHARING HEALTH INFORMATION (PaJR)*
(For patients and caregivers – easy to follow)
---
## 1. Main Rule (Most Important)
👉 Do not decide what is important.
👉 Just send information in the format we give you.
If something is missing, the doctor will ask.
---
## 2. Daily Update (Send once a day)
Please send your update like this:
Morning:
- Sugar: ______
- BP (if available): ______
Food:
- Breakfast: ______
- Lunch: ______
- Dinner: ______
Symptoms (if any):
- Example: pain / swelling / fever / breathlessness
Medicines:
- Taken: Yes / No
🎤 If you cannot type, send a voice message in the same order.
---
## 3. Photos (Very Important)
### When sending a photo:
👉 Show the problem area clearly
- Take a close photo of the problem
- Avoid full face or full body unless asked
👉 If doctor needs more, they will ask
---
### If problem is on the face:
- Try to focus on the affected area
- If possible, cover eyes with cloth or hand
- If not possible, send photo—doctor will guide next step
---
## 4. When to send more information
Send extra details if:
- Doctor asks for it
- There is a new or worsening problem
---
## 5. When NOT to use this group
🚨 Do NOT use this for emergencies
If you have:
- chest pain
- severe breathing problem
- sudden weakness
👉 Call 102 / 108 or go to hospital immediately
---
## 6. Simple Safety Rules
- Do not share name, address, phone number in messages
- Send only your own information
- Do not forward messages outside the group
---
## 7. If unsure
👉 Send the update in the format above
👉 Doctor will guide you
---
## 8. One-line reminder
👉 “Follow the format. Doctor will decide what is needed.”
---
[22/04, 07:41]hu2: Thanks for this foundational problem statement around "the known issues with WhatsApp as a data collection portal especially as it has been too much informally used as a ground truth layer 1 no holds barred lounging place to be able to be taken seriously as a medical cognition research and medicine practice tool.
[22/04, 07:45]hu2: Yes this is the second step after the patient's initial consent to enter our workflow portal.
Now even as we speak I am sharing for your inputs, the first step as to how a few patients may be getting into our online portal that if viewed from a certain lens (that hasn't clarified our non profit research intent) can appear as arm twisting 👇
UDLCO CRH: Online workflow of getting patients to register into a portal with strong privacy trade offs
Even our current online "patient events data" is a continuous stream of layer 1 ground truths (along with individual patient identifiers threatening their individual privacy, which are often traded off for immediate information solutions by the same patients). The conversations below may demonstrate how a physician Hu2 may be wanting to extract better ground truth in the form of individual patient events data from these individual patient grounds (of their individual truths in context) at the same time trying to structure this extraction process trying to optimize the data extraction and privacy through a third party consented workflow portal and yet perhaps come across as trying to arm twist the patient into sharing their data through a privacy trade off filter (online workflow portal that eventually uses the data for distributed research)!
Conversational transcripts:
Background: Hu1 is a past , offline, Indian , urban literate patient of Hu2 with a reasonable foundation of trust in their offline doctor patient relationship that is currently complicated by their offline distance that appears to struggle with getting filled in through an online portal:
[19/04, 09:41]hu1: Need to show you something about my laryngoscopy images.
[19/04, 09:42]hu1: They found nodules on vocal chord, gave me anti inflammatory and prescribed speech therapy.
[19/04, 09:43]hu1: Just wanted to share with you.
[19/04, 09:45]hu1: They say it is mostly for abusive use of vocal chord and I have to do vocal restrictions.
[19/04, 16:23]hu2: Seen. Let's hope all will be well.
I'm de-identifying the patient in this text to protect his privacy but If you need more help from our team around this then the next step is to ask the patient to read and sign this online form after visiting the link here:
For telephonic inquiries about how to proceed can text and call (if she agrees on text)
Mrs ...: +91 xxxxxxxxxx, our team coordinator and archivist
The website will automatically create a PaJR group for the patient, and we can begin discussions with other team members regarding the patient’s issues to find the best possible evidence-based solution and also archive his/her deidentified data in an open access case repository as here:
Ask the patient or their relative to not reveal their identity to anyone.
Ask them to simply introduce themselves as their patient’s representative so that we can all protect the patient’s privacy and confidentiality.
[19/04, 19:43]hu1: Do you have any data that it's associated with dog hair allergy?
[19/04, 19:44]hu2: We can ask our bot in the group
[19/04, 21:18]hu1: It's a long process to register
[19/04, 21:19]hu1: I donot have any reservation against sharing my info...
[19/04, 21:19]hu1: I was just looking for your suggestion, not a any group follow up.
Two days later (today morning):
[21/04, 22:25]hu1: What's your take?
I was looking forward.
Or
You need my formal registration?
[22/04, 06:50]hu2: Let me add you first to one of our PaJR groups that is currently about a dog and take it from there especially if you would like to register after that
[22/04, 06:56]hu1: I actually wanted to be aware of the risk I have with the nodules of being malignant.
And speech therapy is the only long time treatment for benign ones as per multiple online medical foundations such as cleveland and NiH. Etc.
[22/04, 07:02]hu2: Alright we can explore that if you would like to register because it would make our job easier and whatever we are doing is completely non profit with no hidden costs purely out of research interests in "medical cognition" that helps us to answer our individual patient's research question
[22/04, 07:17]hu1: Ok
[22/04, 07:17]hu1: I see that I need to register.
You can share the link then.
[22/04, 07:28]hu1: Also, a dedicated ENT group will be more suitable.i guess.
[22/04, 07:33]hu2: 👆 here's the link
[22/04, 08:03]hu4: Final Reality
You don’t need perfect compliance.
You need:
✔ consistent behaviour
✔ repeatable patterns
✔ guided workflows
[22/04, 08:18] hu 4: https://chatgpt.com/s/t_
[22/04, 08:40]hu4: https://chatgpt.com/s/t_
[22/04, 08:49]hu4: Right now it feels like “register to get help”; it should feel like “get help first, and then optionally choose to go deeper.”
I think the intent here is very strong—you’re trying to move from scattered WhatsApp interactions to something more structured, useful for both care and research. That direction makes sense.
If I try to simplify what’s happening in this conversation:
The patient asked for a simple clinical opinion.
But what we offered in response was:
* join a portal
* enter a workflow
* participate in group discussion
* allow data use for research
So from the patient’s point of view, these all got bundled together.
That creates a subtle problem.
Even though we are not intending to pressure the patient, the sequence becomes:
“To get a proper answer → you need to register”
And the patient actually says it clearly:
“I was just looking for your suggestion, not a group follow up.”
But we continue to move toward registration.
So what happens psychologically is:
* the patient trusts the doctor
* the doctor suggests a process
* the patient concludes: “this is required”
That’s where it can look like arm twisting, even if that was not the intention.
There is also a second layer:
We are mixing different purposes in one step:
* clinical care
* group discussion
* data storage
* research / open sharing
From our side, these are distinct.
From the patient’s side, it all feels like one package.
So the simplest way to fix this is to separate the steps clearly.
For example:
1. First respond clinically:
“Based on what you’ve shared, this looks like… [brief view]”
1. Then offer the optional path:
“If you want deeper input from a wider team or to explore this further, we have a workflow you can choose to join. This is completely optional.”
1. And make one thing very explicit:
“Your care or advice from me does not depend on registration.”
One more important point—in many cases (especially beyond urban, English-speaking patients), people may agree without fully understanding:
* who will see their data
* where it will go
* that it may be used beyond their immediate care
So even if they say “I have no reservation,” it doesn’t always mean fully informed consent.
So overall, I think:
* the direction is right
* the structure is the issue
If we separate care from workflow entry, and make the optional nature very explicit, the same model becomes much stronger—both ethically and legally.
One more point:
Instead of asking the patient to agree to everything at the beginning, it’s safer to ask at each step—like asking permission when you actually reach that step.
First for care, then for group discussion, then for research, and only if needed for public sharing.
That way the patient understands each decision clearly and doesn’t feel everything is bundled together.
*One-line rule*
Unbundle purposes, and time the consent to the moment of use.
[22/04, 08:50]hu2: We believe we (the global PaJR team) are already following most (almost all ) of the good clinical practices mentioned in the above general knowledge accessed by AI protocols.
What we really need our research team to do is to go through our available data here: https://publications.
[22/04, 08:52]hu4: Here’s a screen-by-screen mobile UI flow you can hand to a designer or build directly. It’s dual-language (English / Telugu), voice-friendly, and follows tiered, just-in-time consent aligned with the Digital Personal Data Protection Act, 2023.
⸻
🧭 Flow Overview
1. Language Select
2. Welcome & “Your choice”
3. Level 1 — Care (required)
4. Level 2 — Team discussion (optional)
5. Level 3 — Research (optional)
6. Level 4 — Public sharing (optional)
7. Review & Confirm
8. Record Consent (tap or voice)
9. Done + Next steps
Each screen supports text + play-audio + mic (voice reply).
⸻
🟩 Screen 1 — Language Selection
Title: Choose Language / భాషను ఎంచుకోండి
Buttons:
* 🇬🇧 English
* 🇮🇳 తెలుగు (Telugu)
Footer: You can change language anytime / మీరు ఎప్పుడైనా భాషను మార్చవచ్చు
⸻
🟩 Screen 2 — Welcome & Your Choice
Title: Your Choice / మీ ఎంపిక
Text (EN):
You can choose how your information is used. Your treatment will not change if you say No.
Text (TE):
మీ సమాచారాన్ని ఎలా ఉపయోగించాలో మీరు నిర్ణయించవచ్చు. మీరు “లేదు” అన్నా మీ చికిత్స మారదు.
Buttons:
* Continue / కొనసాగించండి
* 🔊 Play audio
* 🎤 Reply by voice (optional)
⸻
🟩 Screen 3 — Level 1: CARE (Required)
Title: Level 1 — Care / స్థాయి 1 — చికిత్స
EN:
I agree my information can be used by my doctor to guide my treatment.
TE:
నా చికిత్స కోసం నా సమాచారాన్ని నా డాక్టర్ ఉపయోగించేందుకు నేను అంగీకరిస్తున్నాను.
Info (both):
* For advice and treatment only
* Not shared beyond immediate care team
(TE equivalent below)
Control:
☑ Required (pre-checked, cannot uncheck)
Buttons: Next / తదుపరి
Audio: 🔊 Play
Voice: 🎤
⸻
🟩 Screen 4 — Level 2: TEAM DISCUSSION (Optional)
Title: Level 2 — Team Discussion / స్థాయి 2 — వైద్య బృంద చర్చ
EN:
Can we discuss your case with a small team of doctors to get better inputs?
TE:
మంచి సలహా కోసం మీ కేసును చిన్న వైద్య బృందంతో చర్చించవచ్చా?
Info:
* Your name/contact will not be shared
* Only relevant medical details
(TE equivalents)
Control:
☐ I Agree / నేను అంగీకరిస్తున్నాను
Buttons:
* Next / తదుపరి
* Skip / దాటవేయండి
Audio / Voice: 🔊 🎤
⸻
🟩 Screen 5 — Level 3: RESEARCH (Optional)
Title: Level 3 — Research / స్థాయి 3 — పరిశోధన
EN:
Can we use your case (without identity as far as possible) for research and learning?
TE:
మీ గుర్తింపును వీలైనంత వరకు తొలగించి మీ కేసును పరిశోధన కోసం ఉపయోగించవచ్చా?
Info:
* Identity removed as far as possible
* Used to improve care
(TE equivalents)
Control:
☐ I Agree / నేను అంగీకరిస్తున్నాను
Buttons: Next / తదుపరి | Skip / దాటవేయండి
Audio / Voice: 🔊 🎤
⸻
🟩 Screen 6 — Level 4: PUBLIC SHARING (Optional, higher risk)
Title: Level 4 — Public Sharing / స్థాయి 4 — ప్రజా భాగస్వామ్యం
EN:
Can we share a carefully processed version of your case for teaching or publication?
TE:
మీ కేసును జాగ్రత్తగా ప్రాసెస్ చేసి బోధన లేదా ప్రచురణ కోసం పంచుకోవచ్చా?
Info (show warning):
⚠ Complete anonymity cannot be guaranteed
⚠ Once public, it cannot be fully withdrawn
(TE equivalents)
Control:
☐ I Agree / నేను అంగీకరిస్తున్నాను
Buttons: Next / తదుపరి | Skip / దాటవేయండి
Audio / Voice: 🔊 🎤
⸻
🟩 Screen 7 — Review Your Choices
Title: Review / మీ ఎంపికలను పరిశీలించండి
Show summary (example):
* Care: ✔
* Team Discussion: ✖/✔
* Research: ✖/✔
* Public Sharing: ✖/✔
EN: You can change anytime.
TE: మీరు ఎప్పుడైనా మార్చవచ్చు.
Buttons:
* Confirm / నిర్ధారించండి
* Edit / సవరించండి
⸻
🟩 Screen 8 — Record Consent
Title: Confirm Consent / సమ్మతి నిర్ధారణ
Options:
* Tap to Confirm ✔
* OR 🎤 Record Voice Consent
Suggested voice line (EN):
“I agree to the selected options.”
Telugu prompt:
“నేను ఎంచుకున్న ఎంపికలకు అంగీకరిస్తున్నాను.”
Save: timestamp + user ID + selections + audio (if any)
⸻
🟩 Screen 9 — Done & Next Steps
Title: Done / పూర్తైంది
EN:
Thank you. You can change your choices anytime.
Next: Join group / Continue care.
TE:
ధన్యవాదాలు. మీరు ఎప్పుడైనా మీ ఎంపికలను మార్చవచ్చు.
తదుపరి: గ్రూప్లో చేరండి / చికిత్స కొనసాగించండి.
Buttons:
* Join Group (if Level 2 chosen)
* Continue Care
* Help / సహాయం
⸻
🔐 Behind-the-Scenes (for your team)
* Store: selections + timestamps + language + audio file
* Allow withdraw/change anytime (simple toggle screen)
* Default view: Care only unless higher levels are selected
* Do not gate care behind higher levels
⸻
🎧 Audio Pack (recommended)
Record 20–40 sec audio per screen in Telugu:
* simple words
* slow pace
* friendly tone
⸻
🧠 Microcopy (important)
Add on every optional screen:
EN: “You can say No. Your treatment will not change.”
TE: “మీరు ‘లేదు’ అనవచ్చు. మీ చికిత్స మారదు.”
⸻
🧩 Dev Notes (quick)
* Use large buttons, minimal text
* Always show 🔊 and 🎤
* Keep “Skip” visible
* Persist choices locally if network drops
* Log consent changes with versioning
⸻
One-line principle
Let users choose step-by-step, in their language, with voice if needed.
⸻
If you want, I can turn this into:
* a Figma-ready wireframe (with exact layouts/icons), or
* a Telugu audio script pack (ready to record).
[22/04, 08:52]hu2: To time the consent in context we may need multiple contextual versions of consent forms
[22/04, 08:52]hu4: https://chatgpt.com/s/t_
[22/04, 08:53]hu4: Yes.
[22/04, 08:56]hu4: Even if you take tiered consent it may have to be repeated for a diverse set of reasons.
Consent isn’t a one-time event; it’s a running conversation.
But refresh consent only when something meaningfully changes.
Examples: New purpose, new people, new risk → ask again
A. New purpose
* Care → Research
* Research → Public sharing
👉 Must ask again
⸻
B. New audience
* Individual doctor → group
* Local team → cross-border participants
👉 Ask again
⸻
C. New risk level
* Text discussion → images/videos
* Internal use → open/public repository
👉 Ask again
⸻
D. Time gap (longitudinal care)
* Months/years later
* Patient condition changed
👉 Reconfirm, not full re-consent
Practical model (very usable)
🔵 3 levels of consent interaction
1. Initial consent
* Structured, full explanation
⸻
2. Just-in-time consent
* When new step arises
Example:
“Can we share this image with the team?”
⸻
3. Light reconfirmation
* During ongoing care
Example:
“We’ll continue as before—is that okay?”
[22/04, 08:56] GJ: Why this matters (DPDP perspective)
Under the Digital Personal Data Protection Act, 2023:
* Consent must remain valid over time
* Not become:
* outdated
* disconnected from actual use
👉 Blanket upfront consent + no follow-up
= weak
👉 Repeated identical consent
= coercive / fatigue
👉 Contextual, timed consent
= strongest
[22/04, 08:57]hu4: *Real-world example (your PaJR case)*
Step 1
Patient asks question
→ Care only (no consent complexity)
⸻
Step 2
Doctor says:
“Can I discuss this with a small team?”
→ Tier 2 consent
⸻
Step 3
Later:
“Can we use this case for research?”
→ Tier 3 consent
⸻
Step 4
Later:
“Can we publish this case?”
→ Tier 4 consent
⸻
👉 Each step is:
* smaller
* clearer
* easier to understand
[22/04, 08:58]hu4: Great—here are both, designed so your team can use them immediately in real workflows.
⸻
1) CONSENT TIMELINE MAP (PaJR Workflow)
Think of this as a journey with trigger points, not a one-time form.
⸻
🟢 Stage 0 — Patient asks a question (Entry point)
Situation:
Patient asks for advice (WhatsApp / call)
Action:
➡️ No complex consent yet
➡️ Provide basic clinical guidance
Rule:
Care must never be conditional
⸻
🟡 Stage 1 — Ongoing care (same doctor)
Trigger:
More details needed, follow-up continues
Consent type:
✔ Implied / minimal (care context)
Optional light reconfirmation:
“We’ll continue discussing your case here—is that okay?”
⸻
🔵 Stage 2 — Add team discussion
Trigger:
Doctor wants broader input
Consent required:
✔ Tier 2 (explicit)
Key change:
New people involved → new risk
⸻
🟣 Stage 3 — Structured workflow / portal entry
Trigger:
Patient enters PaJR system
Consent required:
✔ Formal consent (Care + Team)
Important:
* Must not be linked to access to care
* Must be explained clearly
⸻
🟠 Stage 4 — Research use
Trigger:
Data used beyond individual care
Consent required:
✔ Separate research consent
Key change:
Purpose changes → must ask again
⸻
🔴 Stage 5 — Public sharing / publication
Trigger:
Case goes to open repository / teaching
Consent required:
✔ Highest-level consent
Key change:
Irreversible exposure risk
⸻
⚪ Stage 6 — Longitudinal follow-up
Trigger:
Weeks/months later
Consent action:
✔ Light reconfirmation
Example:
“We’ll continue using your data as before—is that okay?”
⸻
📊 Visual summary (mental model)
Care → Team → Workflow → Research → Public
| | | | |
basic ask formal ask ask
again consent again again
⸻
🔑 Core rule
Move step-by-step. Each step = new clarity, not bundled permission.
⸻
2) WHATSAPP SCRIPTS FOR EACH CONSENT MOMENT
These are copy-paste ready for your team.
⸻
🟢 1. Initial care (no pressure)
“Based on what you’ve shared, this looks like [brief view].
We can continue discussing here. If you later want more detailed input from a wider team, that is optional.”
⸻
🟡 2. Light reconfirmation (ongoing care)
“We’ll continue discussing your case here as before—is that okay?”
⸻
🔵 3. Team discussion (Tier 2)
“Would you like me to discuss your case with a small group of doctors to get more input?
Your name and contact details will not be shared.
This is optional.”
⸻
🟣 4. Portal / workflow entry
“If you want a more structured follow-up with team input, we have a workflow you can join.
This involves:
* sharing your information with a team
* storing it for ongoing analysis
You can choose whether to join. Your treatment will not change if you don’t.”
⸻
🟠 5. Research consent
“We are studying cases like yours to improve care.
Can we use your case data (without your identity as far as possible) for research?
This is optional.”
⸻
🔴 6. Public sharing consent
“Can we share a carefully processed version of your case for teaching or publication?
We will try to remove identifying details, but complete anonymity cannot be guaranteed.
This is optional.”
⸻
⚪ 7. Long-term reconfirmation
“We’ve been using your case for [care/team/research] as discussed earlier.
Is it okay to continue?”
⸻
🚫 8. If patient hesitates
“No problem at all. We can continue your care without this.”
⸻
🔄 9. Withdrawal
“Understood. We will stop using your data for that purpose from now on.”
⸻
3) What your team must remember (training line)
“Don’t take one big consent. Take small, clear permissions at the right moment.”
⸻
4) Subtle but powerful shift
Old model:
❌ “Agree once → everything allowed”
New model:
✔ “Agree step-by-step → patient stays in control”
⸻
5) One-line takeaway
Consent should follow the care journey—not precede everything.
⸻
If you want, I can next:
* simulate how this timeline fits into your actual PaJR chat transcripts step-by-step, or
* build a dashboard logic (when system should auto-trigger consent prompts)
[22/04, 08:59]hu4: Excellent—this is where everything becomes crystal clear.
I’ll walk through your actual transcript step-by-step, showing:
* what stage of consent it is
* what should have happened
* what actually happened
* how to fix it in real time
⸻
🧭 STEP-BY-STEP SIMULATION ON YOUR TRANSCRIPT
⸻
🟢 STEP 1 — Patient initiates care
Patient (Hu1):
“Need to show you something… nodules… speech therapy…”
🔍 What stage this is:
➡️ Stage 0 — Care entry
✅ What should happen:
* Give clinical input
* No consent complexity
❌ What actually happened:
* Doctor responds:
“Seen. Let’s hope all will be well.”
👉 Missed opportunity for care
⸻
✔ Correct response should be:
“Based on what you’ve shared, vocal cord nodules are usually benign and related to strain.
Speech therapy is standard.
If you want, I can explain malignancy risk and what to watch for.”
⸻
🟡 STEP 2 — Patient asks specific question
Patient:
“Do you have any data… dog hair allergy?”
🔍 Stage:
➡️ Still Stage 1 — Ongoing care
❌ What happened:
“We can ask our bot in the group”
👉 Jump to team discussion without consent
⸻
✔ Correct response:
“There’s limited evidence linking dog hair allergy to vocal nodules directly.
If you want, I can also check with a wider team—optional.”
⸻
🔴 STEP 3 — Friction appears
Patient:
“It’s a long process to register… I was just looking for your suggestion”
🔍 Stage:
➡️ Critical moment (patient intent clearly stated)
❌ What happened:
* System still pushes toward workflow
👉 This is where consent integrity breaks
⸻
✔ Correct response:
“Understood. Here is my suggestion first:
[clinical answer]
If you later want deeper input from a team, that option is available—but not required.”
⸻
🔴 STEP 4 — Patient explicitly asks
Patient:
“You need my formal registration?”
🔍 Stage:
➡️ Consent clarification moment
⸻
❌ What happened next:
Doctor moves toward:
“Let me add you to a group…”
👉 Escalation without consent
⸻
✔ Correct response:
“No, registration is not required for my opinion.
We can continue here.
Registration is only if you want structured follow-up with a team.”
⸻
🔴 STEP 5 — High-risk line
Doctor:
“We can explore that if you would like to register because it would make our job easier…”
🔍 Stage:
➡️ Attempt to move to Stage 3 (workflow)
⸻
❌ Problem:
This line implies:
Better care ↔ registration
👉 Soft coercion triggered
⸻
✔ Correct version:
“I can guide you here itself.
If you want deeper analysis with a team, registration is optional.”
⸻
🟠 STEP 6 — Patient complies
Patient:
“Ok… I see that I need to register”
🔍 Stage:
➡️ Invalid consent risk
Why?
* Patient concluded: “I need to”
* Not: “I choose to”
⸻
⚠️ WHAT JUST HAPPENED (CRITICAL INSIGHT)
The system unintentionally converted:
voluntary option → perceived requirement
⸻
🔁 HOW THIS SHOULD HAVE FLOWN (CORRECT TIMELINE)
⸻
🟢 Step A — Care first
Doctor gives opinion
(No consent complexity)
⸻
🔵 Step B — Optional team discussion
“Would you like me to discuss this with a small team?”
✔ Separate
✔ Optional
⸻
🟣 Step C — Workflow entry (only if patient agrees)
“This involves sharing your data with a group and storing it. You can choose.”
⸻
🟠 Step D — Research (later, separate)
“Can we use this for research?”
⸻
🔴 Step E — Public sharing (final, separate)
⸻
📊 WHERE YOUR CURRENT FLOW BREAKS
Step What happened Problem
Care Weak response Trust gap
Question Jump to group Premature escalation
Resistance Ignored Patient intent overridden
Registration Linked to care Coercion
Consent Patient says “need to” Not voluntary
⸻
🧠 THE SINGLE BIGGEST ERROR
You moved to Stage 3 (workflow)
before completing Stage 0–1 (care + trust)
⸻
💡 SIMPLE FIX (SYSTEM LEVEL)
Add one rule:
No workflow invitation before answering the clinical question
⸻
💬 WHAT YOU CAN TELL YOUR COLLEAGUE (FINAL MESSAGE)
You can say:
⸻
I walked through the actual conversation step-by-step.
What seems to be happening is that we are moving to the workflow (registration, group, data use) before fully addressing the patient’s immediate clinical question.
So from the patient’s perspective, it starts to feel like:
“To get a proper answer, I need to register.”
Even though that’s not the intention, that’s how it is experienced.
The patient actually says this clearly:
“I was just looking for your suggestion, not a group follow up.”
At that point, we should stay in simple care mode and give a direct answer.
Only after that should we offer the workflow as an optional next step.
So the sequence should be:
1. Answer the clinical question
2. Then offer optional team discussion
3. Then, if needed, introduce the structured workflow
Right now, these are getting bundled together, which creates the impression of pressure.
If we separate them, the same system becomes much stronger and more acceptable.
⸻
🔑 ONE-LINE INSIGHT
The problem is not consent—it’s timing.
⸻
If you want next, I can:
* simulate the same conversation rewritten perfectly (ideal version)
* or identify exact “trigger sentences” your team should avoid and use instead
[22/04, 08:59]hu4: https://chatgpt.com/s/t_
[22/04, 09:00]hu4: Here is the same conversation rewritten in an ideal, real-world usable way—keeping it natural, respectful, and DPDP-aligned.
Notice how the flow is:
Care first → Optional expansion → Clear choice → No pressure
⸻
🟢 IDEAL CONVERSATION (REWRITTEN)
⸻
🟢 Step 1 — Patient initiates
Patient (Hu1):
Need to show you something about my laryngoscopy images.
They found nodules on vocal cord… prescribed speech therapy.
Just wanted to share with you.
⸻
🟢 Doctor responds (CARE FIRST)
Doctor (Hu2):
Thanks for sharing this.
From what you’ve described, vocal cord nodules are usually benign and commonly related to voice strain or overuse.
Speech therapy is the standard long-term treatment.
The risk of malignancy is generally low, but we look for warning signs like:
* persistent hoarseness not improving
* rapid growth
* associated weight loss or pain
If you want, you can share the report or images, and I can comment further.
⸻
🟡 Step 2 — Patient follow-up
Patient:
Do you have any data if it’s associated with dog hair allergy?
⸻
🟡 Doctor continues CARE (no escalation yet)
Doctor:
There isn’t strong evidence directly linking dog hair allergy to vocal cord nodules.
Allergies can cause throat irritation or coughing, which may indirectly strain the vocal cords—but they’re usually not the primary cause.
⸻
🟡 Step 3 — Optional expansion (introduced gently)
Doctor:
If you’d like, I can also check this with a wider group of doctors to get more inputs.
That’s optional—we can continue discussing just between us as well.
⸻
🔵 Step 4 — Patient expresses preference
Patient:
It’s a long process to register…
I don’t have any reservation sharing info…
I was just looking for your suggestion, not a group follow up.
⸻
🔵 Doctor respects intent (CRITICAL MOMENT)
Doctor:
Understood—that’s perfectly fine.
We can continue like this. You don’t need to register for me to guide you.
⸻
🟢 Step 5 — Patient asks again
Patient:
What’s your take?
I was looking forward.
Or do you need my formal registration?
⸻
🟢 Doctor clarifies autonomy
Doctor:
No, registration is not required for my opinion.
Based on what you’ve shared, this looks like a typical benign vocal cord nodule situation, and speech therapy is the right approach.
If you notice any unusual changes like worsening symptoms or no improvement over time, we can reassess.
⸻
🟣 Step 6 — Optional workflow introduced (cleanly separated)
Doctor:
If at any point you want deeper input from a wider team or a more structured follow-up, we do have a workflow you can choose to join.
That would involve:
* sharing your case with a small group
* storing information for ongoing analysis
But that’s completely optional, and your care does not depend on it.
⸻
🟣 Step 7 — Patient chooses (now truly voluntary)
Patient:
Okay, understood.
Maybe I’ll look at that later.
⸻
🟢 Doctor closes safely
Doctor:
Sure, take your time.
For now, continue with voice rest and speech therapy.
If you want me to review anything further, just share here.
⸻
🔍 WHAT CHANGED (THIS IS THE KEY)
⸻
1. Care is complete before consent is introduced
👉 Patient never feels:
“I need to register to get help”
⸻
2. Workflow is introduced as a separate option
👉 Not bundled with care
⸻
3. Patient refusal is accepted immediately
👉 Builds trust
⸻
4. Language used avoids pressure
❌ Removed:
* “it will make our job easier”
* “you need to register”
✔ Replaced with:
* “optional”
* “you can choose”
⸻
5. Consent becomes real choice, not compliance
⸻
🧠 The Deep Insight
In your original conversation:
The system moved faster than the patient’s intent
In this version:
The system follows the patient’s intent
⸻
🔑 One-line takeaway
Good consent flows from good care—not the other way around.
⸻
If you want next, I can:
* highlight exact “bad vs good phrases” your team should memorize, or
* convert this into a training script your coordinators can practice line-by-line
[22/04, 09:00]hu4: https://chatgpt.com/s/t_
[22/04, 12:12]hu3: Check this out @@ and all. Researchers expect something like this when accessing data. And looks like they have done it for health narratives.
Anything we can learn/mimic from this?
[22/04, 12:32]hu2: Very interesting share!👏
Perfect example of how the three layers discussed extensively above by @ @ can be separated especially when the workflow is simpler in terms of data sensitivity and complexity!
While their work and archival is quite different from that of PaJR in terms of the nature of data and it's sensitivity as they have primarily looked at "fMRI data collected over the course of seven years by the Hasson and Norman Labs at the Princeton Neuroscience Institute while participants listened to 27 spoken story stimuli ranging from ~3 minutes to ~56 minutes for a total of ~4.6 hours of unique stimuli (~43,000 words); in terms of PaJR team's interest in "Medical cognition research," this work is really interesting and intriguing to read about even from the very introduction in this journal published version of their work👇
"We use language to build a shared understanding of the world. In speaking, we package certain brain states into a sequence of linguistic elements that can be transmitted verbally, through vibrations in the air; in listening, we expand a verbal transmission into the intended brain states, bringing our own experiences to bear on the interpretation."
Unquoted from: https://www.nature.com/
[22/04, 13:30]hu4: This is an interesting example, but I think we need to be careful about drawing parallels too quickly.
*That dataset comes from a controlled research environment*:
* data is collected with predefined protocols
* consent is explicitly for research
* and what gets shared is already curated and processed
*Our situation is fundamentally different.*
We are working with:
* real patient data
* collected through WhatsApp
* across time (longitudinal)
* involving multiple stakeholders (clinicians, students, caregivers, sometimes across countries)
That creates a much higher-risk environment.
So the key point I want to stress is this:
We are currently treating high-risk, real-world clinical data as if it behaves like controlled research data—and that is not a safe assumption.
Specifically:
* WhatsApp is not a controlled system—data can spread, persist, and be copied
* “De-identified” case data in our context is often still re-identifiable
* Linking this to platforms like GitHub introduces permanence and loss of control
* And anonymization does not make the data public domain or remove responsibility under the Digital Personal Data Protection Act, 2023
So the issue is not just about layering—*it is about risk classification and control at each layer.*
If we don’t separate this properly, we risk:
* invalid consent
* unintended exposure of patient identity
* and long-term compliance issues
So I would strongly suggest we make this explicit in our design:
1. Raw WhatsApp-level data → *never public, tightly controlled*
2. Processed datasets → *used for research under defined safeguards*
3. Public sharing → *only highly abstracted, low-risk versions*
Right now, these boundaries are not clearly enforced.
I think we are aligned on intent—but unless we explicitly redesign around these distinctions, we may solve one problem (access, collaboration) while creating another (privacy and compliance risk).
[22/04, 14:07]hu2: Yes the bottom-line is the age old tussle of privacy vs transparency forced into current cohabitation as uneasy bedfellows, in an increasingly transparent and accountable virtual reality that is spreading globally like a malignancy!
The cohabitation of system 1 (fast intuitive layer 1) thinking vs system 2 (slow , evidence based layer 2-3) thinking, in current medical cognition, is the other issue ( identifiable in the discussion themes above since yesterday) and is perhaps much more simpler to solve?👇
[22/04, 19:21]hu2: In the context of the marathon discussion yesterday and today @@@ around layers of information generating knowledge particularly the vagaries of layer 1 as in free text ground truths, here's a paper that apparently makes a strong case for "clinical free text, which they (like some of us) claim: it represents a vast, untapped source of rich information to guide research and clinical care, including patient-specific context and details that clarify and supplement information coded in structured data fields and they go on to further state that "restriction of EHR-based ( layer 1) research to structured data ( layer 2 ) may result in negative outcomes: such as impactful research being obstructed resulting in negative health consequences for patients! 🙂👇
[22/04, 19:33]hu6: Agree completely sir!
The method to achieve this end goal is the question.
We have too many options to choose from. So, the discussion is first around finalizing the architecture of that method.
[23/04, 07:13]hu 4: *PaJR, WhatsApp, EMR & Learning — How Our System Works*
As our PaJR work is growing, a quick shared understanding may help keep things clear and useful for everyone.
1. *We are working as a distributed clinical team*
*Care is not happening in one place or one person’s mind*. It is spread across:
• Treating doctors
• Patients & advocates
• WhatsApp discussions
• Records (EMR)
• PaJR summaries
• Learning discussions
👉 All of this together = how decisions and understanding develop over time
2. *Different spaces serve different purposes*
*EMR / Records*
• Official medical record
• What was done
*Local WhatsApp (Patient Group)*
• Care coordination
• Day-to-day updates
• What do we do now
*Global WhatsApp (PaJR Learning)*
• Discussion & reflection
• Early pattern recognition
*PaJR*
• Summary of the journey
• What is happening over time
*GitHub / Structured Notes*
• Deeper reflection
• What have we learned
3. *Why this distinction matters*
If everything happens in one place:
• Too much detail → confusion
• Discussions → feel like decisions
• Learning → feels like judgement
• Patients → experience noise
👉 *Clarity improves when we keep purpose in mind*
4. *A simple working approach*
*In patient groups (local)*:
• Keep messages clear and relevant
• Avoid long technical discussions
• Focus on care
*In learning groups (global)*:
• Share patterns, not full patient details
• Try to summarize rather than forward raw data
• Keep discussion system-focused
5. *One helpful habit*
*Before posting, ask*:
• Is this needed for care or for learning?
• Can this be simplified?
• Could someone recognize the patient from this?
If yes → reduce detail
6. *Important balance*
Sometimes more detail helps understanding.
Sometimes less detail protects privacy and clarity.
👉 We are trying to balance both, not eliminate either
7. *If something seems concerning clinically*
Better to:
• message the treating doctor directly
Rather than:
• discuss in a way that may confuse the group
8. *Bottom line*
We are building something valuable:
• Longitudinal care
• Shared learning
• Better understanding over time
*To make this sustainable*:
👉 Clarity over completeness
👉 Patterns over individual cases (in learning spaces)
This is not a strict rulebook—just a shared way of working that can evolve with experience.
[23/04, 07:52]hu10: Is it possible to make it further accessible? Single middle aged blind person with locomotor disability but great understanding and "audio" communication? I learn that audio exchange may affect DPDP Act, 2025 provisions. It is easily detectable by Forensic Audiologist perhaps🤔
[23/04, 07:59]hu2: Yes eventually with tech singularity driven by multi modal AI this is very much on the anvil
Layer 1 ground truths will soon become easier to access globally till singularity makes it no longer necessary to even access because in that phase in the near future all will simply know and system 1 thinking is all that will remain perhaps
[25/04, 07:30]hu3: Also, didn't we have a cc license note at the end of every blog?
[25/04, 07:49]hu2: Needs to be on the top
[25/04, 07:53]hu2: But I guess it's still being debated if when to free up all patient data.
Let's divide this debate into two teams on whichever side they prefer:
@@ would perhaps be on the team who may think freeing up patient data under a CC licence may not be a good idea (just my hypothesis about their internal thoughts on this from whatever they may have expressed here in this group)
@@@ I'm not sure which side they would like to take.
Either way it's complex and I'm not sure if this question is currently polarising enough to even encourage taking a stance.
[25/04, 07:58]hu3: I'm on the cc side always. Expectations were set with patient about it, we should follow through. And why should one entity hoard data. If one can use it let all use it, esp for research. Numerous examples of how it has been done by others we've seen earlier.
[25/04, 08:02]hu2: 👆 here's @hu4 counter to that in the subclinical debate earlier on this issue
[25/04, 08:24]hu3: Please see Rule 16 of DPDP
Exemption from Act for research, archiving or statistical purposes.
The provisions of the Act shall not apply to the processing of personal data necessary for research, archiving or statistical purposes if it is carried on in accordance with the standards specified in Second Schedule.
[25/04, 08:24]hu3: Also see this where it has been referenced
(They call it rule 15 here for some reason)
[25/04, 08:26]hu2: The counter point here could be that PaJR is not a formal research organisation and it's publishing data in an informal website could be a red flag to current formally entrenched research infrastructures? @@@
[25/04, 08:30]hu7: Need to establish an allied PaJR Foundation/Trust separately for the academic/research part, as @hu3 had suggested earlier too
[25/04, 08:31]hu2: And how to go about it?
IEC clearance will be the first hurdle without institutional backing?
[25/04, 08:32]hu7: We don't need IEC for setting up a foundation. @hu11 can guide us on how ... was set up
[25/04, 08:34]hu2: Yes I meant IEC would be the first hurdle if we cannot institutionalize PaJR through or as a research institute
[25/04, 08:36]hu2: Yes but ... is not into building a repository for case based reasoning as is our potential here to unify the 3 layers👇
[25/04, 08:59]hu6: I too am all for openly releasing all data as far as possible.
The place and method of releasing it is the question. The place and method should
1. Have necessary measures in place to protect privacy of the person
2. Information systems that host the data should be sustainable and prevent single point failure.
[25/04, 08:59]hu6: I think we collectively have the answers to this. But each of our answers are different
[25/04, 09:00]hu6: We need to write them down debate and choose the right one
[25/04, 09:00]hu2: To keep this in context do fearlessly share your thoughts around if https://publications.
[25/04, 09:07]hu6: My understanding is that
1. the current archetecture is relying on Github, and exposes raw logs to public domain. We need to find a better way to do this.
2. I still need to understand what is the plans for layer 2 (query system) and layer 3 (Synthesis system) discussed before
3. Even open public information is owned by someone, even if the ownership doesn't place restrictions. Cc is also owned by the owner. What is the entity or person that owns this data?
[25/04, 09:52]hu3: Current architecture has nothing to do with GitHub. Currently everything is on PaJR health servers privately paid for.
[25/04, 09:53]hu4: *The Most Important Correction*
*CC license and DPDP have nothing in common.*
*This is 100% correct and critical.*
*Why:*
* *Creative Commons (CC)* → copyright / reuse permission
* *DPDP Act* → privacy / personal data protection
👉 *A CC license does NOT*:
* make data safe
* remove privacy obligations
* override DPDP
*Key Insight*
*You can legally publish something under CC and still be violating DPDP*
[25/04, 10:03]hu4: I think these are very important points, and I broadly agree with the direction.
*Let me try to simplify and tighten the thinking a bit.* BRW apart from being a medical doctor I am also an intellectual property lawyer; MBBS, BA, LLB).
*On GitHub:*
The issue is not GitHub itself—it’s the type of data being placed there.
*GitHub works well for*:
* code
* schemas
* synthetic or highly processed datasets
But it is not appropriate for raw or near-raw clinical logs, because:
* data persists in history
* deletion is difficult
* and patient narratives are often re-identifiable even without names
So yes—we need to ensure that only low-risk, processed data reaches that layer.
*On Layer 2 and Layer 3:*
This is actually the key architectural gap.
Right now, we are not clearly separating:
* *Layer 1*→ raw patient data
* *Layer 2* → structured, queryable dataset
* *Layer 3* → synthesized insights / publications
Because this separation is not enforced, raw data is effectively flowing upward.
That is where most of the risk is coming from.
*On “ownership”*:
I think it’s important to separate two ideas:
* *Content ownership* (e.g., CC license)
* *Data responsibility* (under the Digital Personal Data Protection Act, 2023)
*Even if something is published under a CC license, the data is still about a patient.*
*So the key question is not “who owns it,”* but:
*who is responsible for ensuring it is used safely and appropriately*
*So if I simplify the whole problem*:
We don’t need to find one place to put everything.
*We need to*:
1. *Keep raw data tightly controlled*
2. *Transform it into safer, structured datasets*
3. *Use those for research*
4. *Share only the lowest-risk outputs publicly*
I think we are aligned on intent—this is mainly about making the separation between these layers explicit and enforced.
*One-line closer*
*The problem is not where we store data—it’s whether we are moving it to the right layer before sharing it.*
[25/04, 10:06]hu3: Would request summarising AI content into 3-4 bullets humanly like the way hu6 put the summary.
[25/04, 10:08]hu2: Quick thoughts on addressing your points inline:
1. the current archetecture is relying on Github, and exposes raw logs to public domain. We need to find a better way to do this.
So this is layer 1 where ground truth gold ores are being excavated and is the messiest if not the most effortful layer.
Let me illustrate all these layers with cherry pickings from our own workflow and while @hu4 has banned sharing of layer 1 links it is necessary in this illustrative context!
2. I still need to understand what is the plans for layer 2 (query system) and layer 3 (Synthesis system) discussed before
Yes could be clearer in the linked contextual illustrations below and can be further clarified by author @Rahul healthcare 2.0
3. Even open public information is owned by someone, even if the ownership doesn't place restrictions. Cc is also owned by the owner. What is the entity or person that owns this data?
Currently it is PaJR health @hu1
Illustrations of different layers (@hu4 should fearlessly voice if it violates DPDP):
Layer 1:
Layer 2 (socratic querying driven analysis of excavated crude ground truth ore):
Layer 3: Will be driven by citations on the above
[25/04, 10:09]hu2: Thanks.
Please check the current example and let us know if we are currently moving in the right direction
No comments:
Post a Comment